Category,Data Code,Data Name,Date,Patient Count,Normalized Patient Count
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-04-01,116.0,0.0016313672545214186
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-04-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-04-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-04-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-04-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-04-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-04-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-04-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-04-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-04-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-04-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-04-01,208.0,0.002925210249486682
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-04-01,26.0,0.00036565128118583524
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-04-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-04-01,208.0,0.002925210249486682
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-05-01,146.0,0.002053272578966613
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-05-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-05-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-05-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-05-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-05-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-05-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-05-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-05-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-05-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-05-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-05-01,443.0,0.006230135290974039
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-05-01,23.0,0.00032346074874131577
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-05-01,443.0,0.006230135290974039
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-06-01,235.0,0.0033049250414873567
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-06-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-06-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-06-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-06-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-06-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-06-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-06-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-06-01,82.0,0.001153207886816865
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-06-01,62.0,0.0008719376705200685
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-06-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-06-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-06-01,262.0,0.0036846398334880316
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-06-01,36.0,0.0005062863893342334
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-06-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-06-01,262.0,0.0036846398334880316
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-07-01,978.0,0.01375411357691334
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-07-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-07-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-07-01,33.0,0.00046409585688971395
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-07-01,24.0,0.0003375242595561556
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-07-01,24.0,0.0003375242595561556
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-07-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-07-01,56.0,0.0007875566056310297
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-07-01,342.0,0.0048097206986752175
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-07-01,343.0,0.004823784209490057
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-07-01,23.0,0.00032346074874131577
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-07-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-07-01,356.0,0.005006609850082975
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-07-01,78.0,0.0010969538435575057
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-07-01,62.0,0.0008719376705200685
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-07-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-07-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-07-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-07-01,112.0,0.0015751132112620594
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-07-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-07-01,21.0,0.00029533372711163615
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-08-01,356.0,0.005006609850082975
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-08-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-08-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-08-01,16.0,0.00022501617303743706
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-08-01,29.0,0.00040784181363035465
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-08-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-08-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-08-01,44.0,0.0006187944758529519
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-08-01,29.0,0.00040784181363035465
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-08-01,138.0,0.0019407644924478945
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-08-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-08-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-08-01,138.0,0.0019407644924478945
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-08-01,138.0,0.0019407644924478945
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-08-01,106.0,0.0014907321463730205
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-08-01,13.0,0.00018282564059291762
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-08-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-08-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-08-01,56.0,0.0007875566056310297
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-08-01,34.0,0.00047815936770455374
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-08-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-09-01,1266.0,0.017804404691587207
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-09-01,11.0,0.00015469861896323797
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-09-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-09-01,5.0,7.031755407419908e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-09-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-09-01,52.0,0.0007313025623716705
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-09-01,52.0,0.0007313025623716705
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-09-01,162.0,0.00227828875200405
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-09-01,112.0,0.0015751132112620594
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-09-01,496.0,0.006975501364160548
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-09-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-09-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-09-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-09-01,480.0,0.006750485191123112
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-09-01,496.0,0.006975501364160548
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-09-01,122.0,0.0017157483194104575
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-09-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-09-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-10-01,1583.0,0.02226253761989143
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-10-01,11.0,0.00015469861896323797
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-10-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-10-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-10-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-10-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-10-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-10-01,347.0,0.004880038252749416
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-10-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-10-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-10-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-10-01,157.0,0.0022079711979298513
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-10-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-10-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-10-01,347.0,0.004880038252749416
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-10-01,347.0,0.004880038252749416
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-10-01,21.0,0.00029533372711163615
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-10-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-10-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-10-01,38.0,0.000534413410963913
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-10-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-10-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-11-01,131.0,0.0018423199167440158
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-11-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-11-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-11-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-11-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-11-01,44.0,0.0006187944758529519
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-11-01,44.0,0.0006187944758529519
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-11-01,483.0,0.006792675723567631
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-11-01,106.0,0.0014907321463730205
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-11-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-11-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-11-01,108.0,0.0015188591680027
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-11-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-11-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-11-01,23.0,0.00032346074874131577
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-11-01,186.0,0.0026158130115602057
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-11-01,221.0,0.0031080358900795993
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-11-01,191.0,0.002686130565634405
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-11-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-11-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-11-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-11-01,123.0,0.0017298118302252973
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-11-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-11-01,33.0,0.00046409585688971395
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-11-01,41.0,0.0005766039434084325
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2023-12-01,121.0,0.0017016848085956177
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2023-12-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2023-12-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2023-12-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2023-12-01,41.0,0.0005766039434084325
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2023-12-01,102.0,0.0014344781031136612
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2023-12-01,182.0,0.0025595589683008466
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2023-12-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2023-12-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2023-12-01,115.0,0.0016173037437065788
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2023-12-01,23.0,0.00032346074874131577
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2023-12-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2023-12-01,24.0,0.0003375242595561556
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2023-12-01,102.0,0.0014344781031136612
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2023-12-01,103.0,0.001448541613928501
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2023-12-01,101.0,0.0014204145922988214
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2023-12-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2023-12-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2023-12-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2023-12-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2023-12-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2023-12-01,105.0,0.0014766686355581807
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2023-12-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2023-12-01,35.0,0.0004922228785193936
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2023-12-01,41.0,0.0005766039434084325
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-01-01,155.0,0.0021798441763001713
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-01-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-01-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-01-01,3.0,4.219053244451945e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-01-01,24.0,0.0003375242595561556
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-01-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-01-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-01-01,38.0,0.000534413410963913
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-01-01,73.0,0.0010266362894833065
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-01-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-01-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-01-01,118.0,0.0016594942761510984
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-01-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-01-01,3.0,4.219053244451945e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-01-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-01-01,134.0,0.0018845104491885354
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-01-01,134.0,0.0018845104491885354
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-01-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-01-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-01-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-01-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-01-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-01-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-01-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-01-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-02-01,180.0,0.002531431946671167
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-02-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-02-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-02-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-02-01,24.0,0.0003375242595561556
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-02-01,45.0,0.0006328579866677918
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-02-01,45.0,0.0006328579866677918
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-02-01,28.0,0.00039377830281551486
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-02-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-02-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-02-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-02-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-02-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-02-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-02-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-02-01,38.0,0.000534413410963913
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-02-01,39.0,0.0005484769217787528
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-02-01,52.0,0.0007313025623716705
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-02-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-02-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-02-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-02-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-02-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-02-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-02-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-03-01,1397.0,0.019646724608331223
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-03-01,11.0,0.00015469861896323797
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-03-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-03-01,5.0,7.031755407419908e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-03-01,31.0,0.00043596883526003427
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-03-01,52.0,0.0007313025623716705
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-03-01,52.0,0.0007313025623716705
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-03-01,451.0,0.006342643377492757
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-03-01,132.0,0.0018563834275588558
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-03-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-03-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-03-01,147.0,0.002067336089781453
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-03-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-03-01,451.0,0.006342643377492757
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-03-01,200.0,0.002812702162967963
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-03-01,200.0,0.002812702162967963
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-03-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-03-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-03-01,132.0,0.0018563834275588558
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-03-01,41.0,0.0005766039434084325
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-03-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-04-01,881.0,0.012389953027873877
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-04-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-04-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-04-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-04-01,34.0,0.00047815936770455374
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-04-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-04-01,36.0,0.0005062863893342334
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-04-01,36.0,0.0005062863893342334
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-04-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-04-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-04-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-04-01,187.0,0.0026298765223750457
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-04-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-04-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-04-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-04-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-04-01,48.0,0.0006750485191123112
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-04-01,82.0,0.001153207886816865
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-04-01,23.0,0.00032346074874131577
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-04-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-04-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-04-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-04-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-04-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-05-01,890.0,0.012516524625207436
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-05-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-05-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-05-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-05-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-05-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-05-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-05-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-05-01,210.0,0.0029533372711163615
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-05-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-05-01,13.0,0.00018282564059291762
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-05-01,13.0,0.00018282564059291762
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-05-01,185.0,0.002601749500745366
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-05-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-05-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-05-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-05-01,480.0,0.006750485191123112
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-05-01,482.0,0.006778612212752791
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-05-01,80.0,0.0011250808651871852
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-05-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-05-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-05-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-05-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-05-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-06-01,1098.0,0.015441734874694118
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-06-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-06-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-06-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-06-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-06-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-06-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-06-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-06-01,50.0,0.0007031755407419908
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-06-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-06-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-06-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-06-01,42.0,0.0005906674542232723
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-06-01,25.0,0.0003515877703709954
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-06-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-06-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-06-01,50.0,0.0007031755407419908
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-06-01,488.0,0.00686299327764183
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-06-01,80.0,0.0011250808651871852
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-06-01,16.0,0.00022501617303743706
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-06-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-06-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-06-01,25.0,0.0003515877703709954
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-06-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-07-01,1379.0,0.019393581413664106
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-07-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-07-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-07-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-07-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-07-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-07-01,40.0,0.0005625404325935926
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-07-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-07-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-07-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-07-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-07-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-07-01,20.0,0.0002812702162967963
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-07-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-07-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-07-01,49.0,0.000689112029927151
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-07-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-07-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-07-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-07-01,15.0,0.00021095266222259724
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-07-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-07-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-07-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-08-01,959.0,0.013486906871431384
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-08-01,5.0,7.031755407419908e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-08-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-08-01,46.0,0.0006469214974826315
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-08-01,22.0,0.00030939723792647593
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-08-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-08-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-08-01,19.0,0.0002672067054819565
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-08-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-08-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-08-01,12.0,0.0001687621297780778
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-08-01,13.0,0.00018282564059291762
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-08-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-08-01,3.0,4.219053244451945e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-08-01,6.0,8.43810648890389e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-08-01,16.0,0.00022501617303743706
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-08-01,21.0,0.00029533372711163615
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-08-01,32.0,0.0004500323460748741
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-08-01,0.0,0.0
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-09-01,450.0,0.006328579866677917
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-09-01,8.0,0.00011250808651871853
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-09-01,10.0,0.00014063510814839815
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-09-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-09-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-09-01,11.0,0.00015469861896323797
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-09-01,11.0,0.00015469861896323797
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-09-01,19.0,0.0002672067054819565
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-09-01,19.0,0.0002672067054819565
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-09-01,19.0,0.0002672067054819565
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-09-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-09-01,41.0,0.0005766039434084325
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-09-01,31.0,0.00043596883526003427
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-09-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-09-01,70.0,0.0009844457570387872
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-09-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-09-01,58.0,0.0008156836272607093
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-09-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-09-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-09-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-09-01,53.0,0.0007453660731865103
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-09-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-09-01,44.0,0.0006187944758529519
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-09-01,13.0,0.00018282564059291762
m1 [ante natal care (anc)],1.1,Total number of NEW Pregnant Women registered for ANC ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.a,Out of total number of NEW Pregnant Women registered with age <15 years,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.c,Out of total number of NEW Pregnant Women registered with age >19 to 49 years,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.d,Out of total number of NEW Pregnant Women registered with age >49 years,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks)",2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,2024-10-01,1138.0,0.01600427530728771
m1 [ante natal care (anc)],1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1),2024-10-01,3.0,4.219053244451945e-05
m1 [ante natal care (anc)],1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2),2024-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster),2024-10-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.5,Number of PW provided full course 360 Calcium tablets ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.6,Number of PW given one Albendazole tablet after 1st trimester,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.7,Number of PW received 4 or more ANC check ups,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour,2024-10-01,18.0,0.0002531431946671167
m1 [ante natal care (anc)],1.3.1,New cases of PW with hypertension detected ,2024-10-01,9.0,0.00012657159733355834
m1 [ante natal care (anc)],1.3.1.a,Number of PW with hypertension managed at institution ,2024-10-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.3.2,Number of Eclampsia cases managed during delivery,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.4.1,Number of PW tested for Haemoglobin (Hb ) 4 or more than 4 times for respective ANCs,2024-10-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.4.2,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases),2024-10-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.4.3,Number of PW having Hb level<=7 g/dl (Out of total tested cases),2024-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.4.4,Number of PW treated for severe anaemia (Hb<=7g/dl) (Out of total tested cases),2024-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.5.1,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test),2024-10-01,14.0,0.00019688915140775743
m1 [ante natal care (anc)],1.5.2,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted,2024-10-01,7.0,9.844457570387872e-05
m1 [ante natal care (anc)],1.5.3,Number of PW given Insulin out of total tested positive for GDM,2024-10-01,1.0,1.4063510814839816e-05
m1 [ante natal care (anc)],1.5.4,Number of PW given Metformin out of total tested positive for GDM,2024-10-01,2.0,2.8127021629679632e-05
m1 [ante natal care (anc)],1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis,2024-10-01,30.0,0.0004219053244451945
m1 [ante natal care (anc)],1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM),2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.7.1,Number of Pregnant Women tested positive for Thyroid disorder,2024-10-01,34.0,0.00047815936770455374
m1 [ante natal care (anc)],1.7.2,Number of Pregnant Women treated for thyroid disorder,2024-10-01,78.0,0.0010969538435575057
m1 [ante natal care (anc)],1.8.1,Number of Pregnant Women screened for TB ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.8.2,Number of Pregnant Women identified with Presumptive TB symptoms,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.8.3,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1,Total High Risk Pregnancy (HRP) Intrapartum including following:,2024-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.9.1.a,Number of Pregnant Women with Post-Partum Haemorrhage(Immediately after delivery) in the facility.,2024-10-01,4.0,5.6254043259359264e-05
m1 [ante natal care (anc)],1.9.1.b,Number of Pregnant Women with Sepsis in the facility.,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.c,Number of Pregnant Women identified with Eclampsia in the facility,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.1.d,Number of Pregnant Women identified with obstructed labour in the facility.,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.2,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported),2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.3,Total no. of ANC or PNC cases referred to Higher/ any other facility,2024-10-01,0.0,0.0
m1 [ante natal care (anc)],1.9.4,Total no. of ANC or PNC cases referred in to the facility,2024-10-01,64.0,0.0009000646921497482
m1 [ante natal care (anc)],1.9.5,Number of Complicated pregnancies treated with Blood Transfusion,2024-10-01,9.0,0.00012657159733355834
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-04-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-04-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-04-01,38.0,0.000534413410963913
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-04-01,18.0,0.0002531431946671167
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-04-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-05-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-05-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-05-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-05-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-05-01,2.0,2.8127021629679632e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-05-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-06-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-06-01,2.0,2.8127021629679632e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-06-01,5.0,7.031755407419908e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-06-01,5.0,7.031755407419908e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-06-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-06-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-07-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-07-01,11.0,0.00015469861896323797
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-07-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-07-01,60.0,0.000843810648890389
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-07-01,60.0,0.000843810648890389
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-07-01,60.0,0.000843810648890389
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-07-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-08-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-08-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-08-01,48.0,0.0006750485191123112
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-08-01,48.0,0.0006750485191123112
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-08-01,72.0,0.0010125727786684667
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-08-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-09-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-09-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-09-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-09-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-09-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-09-01,45.0,0.0006328579866677918
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-09-01,27.0,0.000379714792000675
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-09-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-10-01,61.0,0.0008578741597052288
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-10-01,19.0,0.0002672067054819565
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-10-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-10-01,51.0,0.0007172390515568306
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-10-01,51.0,0.0007172390515568306
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-10-01,51.0,0.0007172390515568306
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-10-01,32.0,0.0004500323460748741
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-10-01,26.0,0.00036565128118583524
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-10-01,11.0,0.00015469861896323797
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-11-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-11-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-11-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-11-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-11-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-11-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-11-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-11-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-11-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-11-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2023-12-01,14.0,0.00019688915140775743
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2023-12-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2023-12-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2023-12-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2023-12-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2023-12-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2023-12-01,34.0,0.00047815936770455374
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2023-12-01,16.0,0.00022501617303743706
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2023-12-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-01-01,5.0,7.031755407419908e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-01-01,5.0,7.031755407419908e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-01-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-01-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-01-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-01-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-01-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-01-01,15.0,0.00021095266222259724
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-01-01,17.0,0.00023907968385227687
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-01-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-02-01,19.0,0.0002672067054819565
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-02-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-02-01,5.0,7.031755407419908e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-02-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-02-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-02-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-02-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-02-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-02-01,23.0,0.00032346074874131577
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-02-01,19.0,0.0002672067054819565
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-02-01,9.0,0.00012657159733355834
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-03-01,12.0,0.0001687621297780778
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-03-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-03-01,2.0,2.8127021629679632e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-03-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-03-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-03-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-03-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-03-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-03-01,22.0,0.00030939723792647593
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-03-01,12.0,0.0001687621297780778
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-03-01,21.0,0.00029533372711163615
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-04-01,11.0,0.00015469861896323797
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-04-01,7.0,9.844457570387872e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-04-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-04-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-04-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-04-01,2.0,2.8127021629679632e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-04-01,11.0,0.00015469861896323797
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-05-01,118.0,0.0016594942761510984
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-05-01,118.0,0.0016594942761510984
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-05-01,118.0,0.0016594942761510984
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-05-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-05-01,18.0,0.0002531431946671167
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-05-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-05-01,38.0,0.000534413410963913
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-06-01,24.0,0.0003375242595561556
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-06-01,24.0,0.0003375242595561556
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-06-01,24.0,0.0003375242595561556
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-06-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-06-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-06-01,2.0,2.8127021629679632e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-06-01,24.0,0.0003375242595561556
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-07-01,28.0,0.00039377830281551486
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-07-01,28.0,0.00039377830281551486
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-07-01,28.0,0.00039377830281551486
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-07-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-07-01,15.0,0.00021095266222259724
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-07-01,4.0,5.6254043259359264e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-07-01,14.0,0.00019688915140775743
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-08-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-08-01,18.0,0.0002531431946671167
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-08-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-08-01,8.0,0.00011250808651871853
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-09-01,14.0,0.00019688915140775743
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-09-01,16.0,0.00022501617303743706
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-09-01,1.0,1.4063510814839816e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-09-01,22.0,0.00030939723792647593
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-09-01,22.0,0.00030939723792647593
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-09-01,22.0,0.00030939723792647593
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-09-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-09-01,44.0,0.0006187944758529519
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-09-01,14.0,0.00019688915140775743
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-09-01,6.0,8.43810648890389e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.1,Childhood Diseases - Pneumonia,2024-10-01,20.0,0.0002812702162967963
m10 [number of cases of childhood diseases (0-5 years)],10.1.2,Childhood Diseases - Asthma,2024-10-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.1.3,Childhood Diseases - Sepsis ,2024-10-01,3.0,4.219053244451945e-05
m10 [number of cases of childhood diseases (0-5 years)],10.1.4,Childhood Diseases - Diphtheria ,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.5,Childhood Diseases - Pertussis ,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.6,Childhood Diseases - Tetanus Neonatorum,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.7,Childhood Diseases - Tuberculosis (TB),2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.8,Childhood Diseases - Acute Flaccid Paralysis(AFP),2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.9,Childhood Diseases - Measles,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.10,Childhood Diseases - Malaria,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.11,Childhood Diseases - Diarrhoea ,2024-10-01,20.0,0.0002812702162967963
m10 [number of cases of childhood diseases (0-5 years)],10.1.12,Childhood Diseases - Diarrhoea treated with ORS,2024-10-01,20.0,0.0002812702162967963
m10 [number of cases of childhood diseases (0-5 years)],10.1.13,Childhood Diseases - Diarrhoea treated with Zinc for 14 days,2024-10-01,20.0,0.0002812702162967963
m10 [number of cases of childhood diseases (0-5 years)],10.1.14,Childhood Diseases -Leprosy Cases,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.1.15,Childhood Diseases- Leprosy with Grade II disability ,2024-10-01,0.0,0.0
m10 [number of cases of childhood diseases (0-5 years)],10.2.1,Children admitted with Respiratory Infections,2024-10-01,16.0,0.00022501617303743706
m10 [number of cases of childhood diseases (0-5 years)],10.2.2,Children admitted with Pneumonia,2024-10-01,10.0,0.00014063510814839815
m10 [number of cases of childhood diseases (0-5 years)],10.2.3,Children admitted with Diarrhoea ,2024-10-01,12.0,0.0001687621297780778
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-04-01,47.0,0.0006609850082974713
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-04-01,43.0,0.0006047309650381121
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-04-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-04-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-04-01,0.0,0.0
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-04-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-04-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-04-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-04-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-04-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-04-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-05-01,24.0,0.0003375242595561556
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-05-01,33.0,0.00046409585688971395
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-05-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-05-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-05-01,0.0,0.0
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-05-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-05-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-05-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-05-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-05-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-05-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-06-01,28.0,0.00039377830281551486
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-06-01,47.0,0.0006609850082974713
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-06-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-06-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-06-01,0.0,0.0
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-06-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-06-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-06-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-06-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-06-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-06-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-06-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-07-01,40.0,0.0005625404325935926
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-07-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-07-01,55.0,0.0007734930948161898
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-07-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-07-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-07-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-07-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-07-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-07-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-07-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-07-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-07-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-07-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-07-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-08-01,98.0,0.001378224059854302
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-08-01,81.0,0.001139144376002025
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-08-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-08-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-08-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-08-01,8.0,0.00011250808651871853
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-08-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-08-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-08-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-08-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-08-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-08-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-08-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-09-01,101.0,0.0014204145922988214
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-09-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-09-01,87.0,0.001223525440891064
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-09-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-09-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-09-01,5.0,7.031755407419908e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-09-01,5.0,7.031755407419908e-05
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-09-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-09-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-09-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-09-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-09-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-09-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-09-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-10-01,137.0,0.0019267009816330547
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-10-01,82.0,0.001153207886816865
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-10-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-10-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-10-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-10-01,0.0,0.0
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-10-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-10-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-10-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-10-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-10-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-10-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-10-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-11-01,104.0,0.001462605124743341
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-11-01,51.0,0.0007172390515568306
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-11-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-11-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-11-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-11-01,7.0,9.844457570387872e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-11-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-11-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-11-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-11-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-11-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-11-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-11-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-11-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2023-12-01,117.0,0.0016454307653362584
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2023-12-01,37.0,0.0005203499001490731
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2023-12-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2023-12-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-12-01,5.0,7.031755407419908e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2023-12-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2023-12-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2023-12-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2023-12-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2023-12-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2023-12-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2023-12-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-01-01,96.0,0.0013500970382246224
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-01-01,33.0,0.00046409585688971395
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-01-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-01-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-01-01,40.0,0.0005625404325935926
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-01-01,22.0,0.00030939723792647593
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-01-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-01-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-01-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-01-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-01-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-01-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-01-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-02-01,85.0,0.0011953984192613844
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-02-01,82.0,0.001153207886816865
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-02-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-02-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-02-01,14.0,0.00019688915140775743
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-02-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-02-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-02-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-02-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-02-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-02-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-02-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-02-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-03-01,110.0,0.0015469861896323797
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-03-01,22.0,0.00030939723792647593
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-03-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-03-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-03-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-03-01,3.0,4.219053244451945e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-03-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-03-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-03-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-03-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-03-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-03-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-03-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-04-01,86.0,0.0012094619300762242
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-04-01,10.0,0.00014063510814839815
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-04-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-04-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-04-01,12.0,0.0001687621297780778
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-04-01,8.0,0.00011250808651871853
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-04-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-04-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-04-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-04-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-04-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-04-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-04-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-05-01,91.0,0.0012797794841504233
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-05-01,9.0,0.00012657159733355834
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-05-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-05-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-05-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-05-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-05-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-05-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-05-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-05-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-05-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-05-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-06-01,115.0,0.0016173037437065788
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-06-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-06-01,28.0,0.00039377830281551486
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-06-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-06-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-06-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-06-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-06-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-06-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-06-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-06-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-06-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-06-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-07-01,176.0,0.0024751779034118074
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-07-01,46.0,0.0006469214974826315
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-07-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-07-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-07-01,2.0,2.8127021629679632e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-07-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-07-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-07-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-07-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-07-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-07-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-07-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-08-01,251.0,0.0035299412145247937
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-08-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-08-01,41.0,0.0005766039434084325
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-08-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-08-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-08-01,3.0,4.219053244451945e-05
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-08-01,0.0,0.0
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-08-01,3.0,4.219053244451945e-05
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-08-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-08-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-08-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-08-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-08-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-08-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-09-01,266.0,0.003740893876747391
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-09-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-09-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-09-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-09-01,46.0,0.0006469214974826315
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-09-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-09-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-09-01,1.0,1.4063510814839816e-05
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-09-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-09-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-09-01,66.0,0.0009281917137794279
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-09-01,10.0,0.00014063510814839815
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-09-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-09-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-09-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-09-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-09-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-09-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-09-01,0.0,0.0
m11 [nvbdcp],11.1.1.a,Total Blood Smears Examined for Malaria ,2024-10-01,152.0,0.002137653643855652
m11 [nvbdcp],11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.1.2.a,RDT conducted for Malaria,2024-10-01,28.0,0.00039377830281551486
m11 [nvbdcp],11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.1.2.d,Malaria (RDT) - Mixed test positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.2.1,Kala Azar (RDT) - Tests Conducted,2024-10-01,0.0,0.0
m11 [nvbdcp],11.2.2,Kala Azar Positive Cases,2024-10-01,0.0,0.0
m11 [nvbdcp],11.3.1,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-10-01,45.0,0.0006328579866677918
m11 [nvbdcp],11.3.2,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-10-01,20.0,0.0002812702162967963
m11 [nvbdcp],11.3.3,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted,2024-10-01,0.0,0.0
m11 [nvbdcp],11.3.4,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive,2024-10-01,0.0,0.0
m11 [nvbdcp],11.4.1,No. of AES cases tested for JE(IgM ELISA),2024-10-01,0.0,0.0
m11 [nvbdcp],11.4.2,No. of JE positive cases,2024-10-01,0.0,0.0
m11 [nvbdcp],11.5.1,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,2024-10-01,0.0,0.0
m11 [nvbdcp],11.5.2,Number of Lymphatic Filarisis lymphoedema patients received MMDP(Morbidity Management And Disability Prevention) kits ,2024-10-01,0.0,0.0
m11 [nvbdcp],11.5.3,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP),2024-10-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-04-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-04-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-04-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-04-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-04-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-04-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-04-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-04-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-04-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-04-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-04-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-04-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-04-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-04-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-04-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-04-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-04-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-04-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-04-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-04-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-05-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-05-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-05-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-05-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-05-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-05-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-05-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-05-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-05-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-05-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-05-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-05-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-05-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-05-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-05-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-05-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-05-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-05-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-05-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-05-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-06-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-06-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-06-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-06-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-06-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-06-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-06-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-06-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-06-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-06-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-06-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-06-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-06-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-06-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-06-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-06-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-06-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-06-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-06-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-06-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-07-01,19.0,0.0002672067054819565
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-07-01,8.0,0.00011250808651871853
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-07-01,12.0,0.0001687621297780778
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-07-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-07-01,19.0,0.0002672067054819565
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-07-01,8.0,0.00011250808651871853
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-07-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-07-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-07-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-07-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-07-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-07-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-07-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-07-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-07-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-07-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-07-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-07-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-07-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-07-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-08-01,20.0,0.0002812702162967963
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-08-01,8.0,0.00011250808651871853
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-08-01,14.0,0.00019688915140775743
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-08-01,5.0,7.031755407419908e-05
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-08-01,20.0,0.0002812702162967963
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-08-01,8.0,0.00011250808651871853
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-08-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-08-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-08-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-08-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-08-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-08-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-08-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-08-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-08-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-08-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-08-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-08-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-08-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-08-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-09-01,36.0,0.0005062863893342334
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-09-01,24.0,0.0003375242595561556
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-09-01,36.0,0.0005062863893342334
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-09-01,24.0,0.0003375242595561556
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-09-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-09-01,4.0,5.6254043259359264e-05
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-09-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-09-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-09-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-09-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-09-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-09-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-09-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-09-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-09-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-09-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-09-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-09-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-09-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-09-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-10-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-10-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-10-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-10-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-10-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-10-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-10-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-10-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-10-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-10-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-10-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-10-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-10-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-10-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-10-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-11-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-11-01,8.0,0.00011250808651871853
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-11-01,8.0,0.00011250808651871853
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-11-01,4.0,5.6254043259359264e-05
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-11-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-11-01,8.0,0.00011250808651871853
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-11-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-11-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-11-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-11-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-11-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-11-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-11-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-11-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-11-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-11-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-11-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-11-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-11-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-11-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2023-12-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2023-12-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2023-12-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2023-12-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2023-12-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2023-12-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2023-12-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2023-12-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2023-12-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2023-12-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2023-12-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2023-12-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2023-12-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2023-12-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2023-12-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2023-12-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2023-12-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2023-12-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2023-12-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2023-12-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-01-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-01-01,7.0,9.844457570387872e-05
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-01-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-01-01,7.0,9.844457570387872e-05
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-01-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-01-01,6.0,8.43810648890389e-05
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-01-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-01-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-01-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-01-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-01-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-01-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-01-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-01-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-01-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-01-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-01-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-01-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-01-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-01-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-02-01,126.0,0.0017720023626698169
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-02-01,119.0,0.0016735577869659382
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-02-01,126.0,0.0017720023626698169
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-02-01,119.0,0.0016735577869659382
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-02-01,126.0,0.0017720023626698169
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-02-01,119.0,0.0016735577869659382
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-02-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-02-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-02-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-02-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-02-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-02-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-02-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-02-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-02-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-02-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-02-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-02-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-02-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-02-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-03-01,20.0,0.0002812702162967963
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-03-01,11.0,0.00015469861896323797
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-03-01,16.0,0.00022501617303743706
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-03-01,8.0,0.00011250808651871853
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-03-01,20.0,0.0002812702162967963
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-03-01,11.0,0.00015469861896323797
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-03-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-03-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-03-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-03-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-03-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-03-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-03-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-03-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-03-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-03-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-03-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-03-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-03-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-03-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-04-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-04-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-04-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-04-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-04-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-04-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-04-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-04-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-04-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-04-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-04-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-04-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-04-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-04-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-04-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-04-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-04-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-04-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-04-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-04-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-05-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-05-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-05-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-05-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-05-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-05-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-05-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-05-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-05-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-05-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-05-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-05-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-05-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-05-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-05-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-05-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-05-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-05-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-05-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-05-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-06-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-06-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-06-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-06-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-06-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-06-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-06-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-06-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-06-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-06-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-06-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-06-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-06-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-06-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-06-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-06-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-06-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-06-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-06-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-06-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-07-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-07-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-07-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-07-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-07-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-07-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-07-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-07-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-07-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-07-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-07-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-07-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-07-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-07-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-07-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-07-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-07-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-07-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-07-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-07-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-08-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-08-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-08-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-08-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-08-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-08-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-08-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-08-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-08-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-08-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-08-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-08-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-08-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-08-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-08-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-08-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-08-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-08-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-08-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-08-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-09-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-09-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-09-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-09-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-09-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-09-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-09-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-09-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-09-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-09-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-09-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-09-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-09-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-09-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-09-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-09-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-09-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-09-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-09-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-09-01,0.0,0.0
m12 [adolescent health],12.1.1.a,Girls registered in AFHC,2024-10-01,0.0,0.0
m12 [adolescent health],12.1.1.b,Boys registered in AFHC,2024-10-01,0.0,0.0
m12 [adolescent health],12.1.2.a,"Out of Girls registered, Girls received clinical services",2024-10-01,0.0,0.0
m12 [adolescent health],12.1.2.b,"Out of Boys registered, Boys received clinical services",2024-10-01,0.0,0.0
m12 [adolescent health],12.1.3.a,"Out of Girls registered, Girls received counselling",2024-10-01,0.0,0.0
m12 [adolescent health],12.1.3.b,"Out of Boys registered, Boys received counselling",2024-10-01,0.0,0.0
m12 [adolescent health],12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,2024-10-01,0.0,0.0
m12 [adolescent health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,2024-10-01,0.0,0.0
m12 [adolescent health],12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,2024-10-01,0.0,0.0
m12 [adolescent health],12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,2024-10-01,0.0,0.0
m12 [adolescent health],12.2.3,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,2024-10-01,0.0,0.0
m12 [adolescent health],12.2.4,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,2024-10-01,0.0,0.0
m12 [adolescent health],12.3.1,Number of adolescent girls provided sanitary napkin packs by ASHA,2024-10-01,0.0,0.0
m12 [adolescent health],12.3.2,Number of sanitary napkin packs distributed free to ASHA (for her personal use),2024-10-01,0.0,0.0
m12 [adolescent health],12.3.3,Number of adolescent girls attended monthly meeting,2024-10-01,0.0,0.0
m12 [adolescent health],12.3.4,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS),2024-10-01,0.0,0.0
m12 [adolescent health],12.4.1,Number of Peer Educators selected,2024-10-01,0.0,0.0
m12 [adolescent health],12.4.2,"Out of the selected Peer Educators, numbers trained",2024-10-01,0.0,0.0
m12 [adolescent health],12.4.3,Number of Adolescent Health & Wellness Days organized,2024-10-01,0.0,0.0
m12 [adolescent health],12.4.4,Number of Adolescent Friendly Club Meetings organized,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-07-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-07-01,8.0,0.00011250808651871853
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-07-01,8.0,0.00011250808651871853
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-07-01,8.0,0.00011250808651871853
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-07-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-07-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-08-01,6.0,8.43810648890389e-05
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-10-01,10.0,0.00014063510814839815
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-10-01,10.0,0.00014063510814839815
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-10-01,10.0,0.00014063510814839815
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-10-01,10.0,0.00014063510814839815
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-11-01,6.0,8.43810648890389e-05
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-11-01,6.0,8.43810648890389e-05
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-11-01,6.0,8.43810648890389e-05
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-11-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2023-12-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-01-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-01-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-01-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-01-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-01-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-02-01,1.0,1.4063510814839816e-05
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-02-01,2.0,2.8127021629679632e-05
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-02-01,2.0,2.8127021629679632e-05
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-02-01,2.0,2.8127021629679632e-05
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-02-01,2.0,2.8127021629679632e-05
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-02-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-03-01,3.0,4.219053244451945e-05
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-03-01,3.0,4.219053244451945e-05
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-03-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-04-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-05-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-06-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-07-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-08-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-09-01,4.0,5.6254043259359264e-05
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-09-01,4.0,5.6254043259359264e-05
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-09-01,4.0,5.6254043259359264e-05
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-09-01,4.0,5.6254043259359264e-05
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-09-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,Number of notified TB patients who are on Anti Tuberculosis Therapy,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.2,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified ,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.a,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing within the facility,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.3.b,Number of Presumptive TB (ie with 4 Symptom complex of TB) identified and sent for any TB testing outside the facility,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.4,"Of the number sent for testing, number who were tested (by any test) for TB within the facility",2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.5,"Of the number sent for testing, number who were tested (by any test) for TB outside the facility",2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.6,"Of the number tested, number of persons diagnosed as TB patients.",2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.7,Number of TB patients availing treatment through a Treatment supporter for the reporting month,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.8,Number of beneficiarys who are registered at the ICTC centre.,2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.9,"Of the number registered at the ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis.",2024-10-01,0.0,0.0
m13 [national tb elimination programme (ntep)],13.1,"Number of Directly Observed Treatment, Short-course (DOTS) cases completed successfully ",2024-10-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-04-01,700.0,0.009844457570387872
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-04-01,575.0,0.008086518718532894
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-04-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-04-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-04-01,142.0,0.001997018535707254
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-04-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-04-01,1149.0,0.016158973926250948
m14 [patient services],14.1.8,Outpatient - Dental,2023-04-01,864.0,0.0121508733440216
m14 [patient services],14.1.9,Outpatient - ENT ,2023-04-01,721.0,0.010139791297499508
m14 [patient services],14.1.10,Outpatients- Asthma,2023-04-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-04-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-04-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-04-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-04-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-04-01,16.0,0.00022501617303743706
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-04-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-04-01,950.0,0.013360335274097825
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-04-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-04-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-04-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-04-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-04-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-04-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-04-01,645.0,0.009070964475571682
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-04-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-04-01,15866.0,0.2231316625882485
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-04-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-04-01,71.0,0.000998509267853627
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-04-01,561.0,0.007889629567125137
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-04-01,67.0,0.0009422552245942677
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-04-01,611.0,0.008592805107867127
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-04-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-04-01,102.0,0.0014344781031136612
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-04-01,481.0,0.006764548701937952
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-04-01,95.0,0.0013360335274097824
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-04-01,564.0,0.007931820099569655
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-04-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-04-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-04-01,6.0,8.43810648890389e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-04-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-04-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-04-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-04-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-04-01,8.0,0.00011250808651871853
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-04-01,8.0,0.00011250808651871853
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-04-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-04-01,34.0,0.00047815936770455374
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-04-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-04-01,288.0,0.004050291114673867
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-04-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-04-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-04-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-04-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-04-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-04-01,33.0,0.00046409585688971395
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-04-01,4.0,5.6254043259359264e-05
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-04-01,14.0,0.00019688915140775743
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-04-01,7.0,9.844457570387872e-05
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-04-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-04-01,75.0,0.0010547633111129863
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-04-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-04-01,1541.0,0.021671870165668156
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-04-01,580.0,0.008156836272607094
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-04-01,81.0,0.001139144376002025
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-04-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-04-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-04-01,21.0,0.00029533372711163615
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-04-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-04-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-04-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-04-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-04-01,450.0,0.006328579866677917
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-04-01,24.0,0.0003375242595561556
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-04-01,274.0,0.0038534019632661095
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-04-01,5.0,7.031755407419908e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-04-01,25.0,0.0003515877703709954
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-04-01,0.0,0.0
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-04-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-04-01,7099.0,0.09983686327454785
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-04-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-04-01,0.0,0.0
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-04-01,0.0,0.0
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-04-01,0.0,0.0
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-04-01,0.0,0.0
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-04-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-04-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-04-01,95.0,0.0013360335274097824
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-04-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-04-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-04-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-04-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-04-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-04-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-04-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-04-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-04-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-04-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-04-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-04-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-04-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-04-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-04-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-04-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-04-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-04-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-04-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2023-04-01,0.0,0.0
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-04-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-04-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-04-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-04-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-04-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-04-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-04-01,0.0,0.0
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-04-01,0.0,0.0
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-04-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-04-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-04-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-04-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-04-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-04-01,0.0,0.0
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-04-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-04-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-04-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-04-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-04-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-05-01,712.0,0.01001321970016595
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-05-01,670.0,0.009422552245942677
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-05-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-05-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-05-01,178.0,0.0025033049250414875
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-05-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-05-01,1389.0,0.019534216521812503
m14 [patient services],14.1.8,Outpatient - Dental,2023-05-01,919.0,0.01292436643883779
m14 [patient services],14.1.9,Outpatient - ENT ,2023-05-01,1035.0,0.01455573369335921
m14 [patient services],14.1.10,Outpatients- Asthma,2023-05-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-05-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-05-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-05-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-05-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-05-01,12.0,0.0001687621297780778
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-05-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-05-01,1055.0,0.014837003909656006
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-05-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-05-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-05-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-05-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-05-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-05-01,634.0,0.008916265856608444
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-05-01,0.0,0.0
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-05-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-05-01,18315.0,0.25757320057379124
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-05-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-05-01,130.0,0.001828256405929176
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-05-01,530.0,0.007453660731865102
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-05-01,100.0,0.0014063510814839816
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-05-01,651.0,0.00915534554046072
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-05-01,125.0,0.001757938851854977
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-05-01,525.0,0.007383343177790903
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-05-01,88.0,0.0012375889517059037
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-05-01,640.0,0.009000646921497482
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-05-01,10.0,0.00014063510814839815
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-05-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-05-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-05-01,11.0,0.00015469861896323797
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-05-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-05-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-05-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-05-01,41.0,0.0005766039434084325
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-05-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-05-01,361.0,0.005076927404157173
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-05-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-05-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-05-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-05-01,5.0,7.031755407419908e-05
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-05-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-05-01,41.0,0.0005766039434084325
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-05-01,16.0,0.00022501617303743706
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-05-01,11.0,0.00015469861896323797
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-05-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-05-01,111.0,0.0015610497004472197
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-05-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-05-01,1512.0,0.021264028352037802
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-05-01,470.0,0.0066098500829747135
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-05-01,104.0,0.001462605124743341
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-05-01,7.0,9.844457570387872e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-05-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-05-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-05-01,26.0,0.00036565128118583524
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-05-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-05-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-05-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-05-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-05-01,6.0,8.43810648890389e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-05-01,537.0,0.0075521053075689815
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-05-01,26.0,0.00036565128118583524
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-05-01,309.0,0.0043456248417855035
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-05-01,4.0,5.6254043259359264e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-05-01,20.0,0.0002812702162967963
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-05-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-05-01,0.0,0.0
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-05-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-05-01,7351.0,0.1033808679998875
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-05-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-05-01,0.0,0.0
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-05-01,0.0,0.0
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-05-01,0.0,0.0
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-05-01,0.0,0.0
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-05-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-05-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-05-01,109.0,0.0015329226788175399
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-05-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-05-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-05-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-05-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-05-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-05-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-05-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-05-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-05-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-05-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-05-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-05-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-05-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-05-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-05-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-05-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-05-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-05-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-05-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2023-05-01,0.0,0.0
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-05-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-05-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-05-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-05-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-05-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-05-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-05-01,0.0,0.0
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-05-01,0.0,0.0
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-05-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-05-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-05-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-05-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-05-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-05-01,0.0,0.0
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-05-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-05-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-05-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-05-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-05-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-06-01,770.0,0.010828903327426658
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-06-01,680.0,0.009563187354091075
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-06-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-06-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-06-01,223.0,0.003136162911709279
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-06-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-06-01,1365.0,0.01919669226225635
m14 [patient services],14.1.8,Outpatient - Dental,2023-06-01,287.0,0.004036227603859027
m14 [patient services],14.1.9,Outpatient - ENT ,2023-06-01,950.0,0.013360335274097825
m14 [patient services],14.1.10,Outpatients- Asthma,2023-06-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-06-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-06-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-06-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-06-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-06-01,15.0,0.00021095266222259724
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-06-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-06-01,1040.0,0.014626051247433408
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-06-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-06-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-06-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-06-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-06-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-06-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-06-01,734.0,0.010322616938092425
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-06-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-06-01,19063.0,0.26809270666329144
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-06-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-06-01,79.0,0.0011110173543723454
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-06-01,645.0,0.009070964475571682
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-06-01,95.0,0.0013360335274097824
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-06-01,636.0,0.008944392878238124
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-06-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-06-01,122.0,0.0017157483194104575
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-06-01,588.0,0.008269344359125812
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-06-01,99.0,0.0013922875706691418
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-06-01,654.0,0.00919753607290524
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-06-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-06-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-06-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-06-01,8.0,0.00011250808651871853
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-06-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-06-01,10.0,0.00014063510814839815
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-06-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-06-01,45.0,0.0006328579866677918
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-06-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-06-01,346.0,0.004865974741934577
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-06-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-06-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-06-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-06-01,9.0,0.00012657159733355834
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-06-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-06-01,38.0,0.000534413410963913
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-06-01,5.0,7.031755407419908e-05
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-06-01,12.0,0.0001687621297780778
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-06-01,14.0,0.00019688915140775743
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-06-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-06-01,130.0,0.001828256405929176
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-06-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-06-01,1276.0,0.017945039799735604
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-06-01,355.0,0.004992546339268135
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-06-01,71.0,0.000998509267853627
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-06-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-06-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-06-01,30.0,0.0004219053244451945
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-06-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-06-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-06-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-06-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-06-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-06-01,538.0,0.007566168818383821
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-06-01,24.0,0.0003375242595561556
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-06-01,320.0,0.004500323460748741
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-06-01,18.0,0.0002531431946671167
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-06-01,0.0,0.0
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-06-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-06-01,7950.0,0.11180491097797654
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-06-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-06-01,0.0,0.0
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-06-01,0.0,0.0
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-06-01,0.0,0.0
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-06-01,0.0,0.0
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-06-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-06-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-06-01,112.0,0.0015751132112620594
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-06-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-06-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-06-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-06-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-06-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-06-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-06-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-06-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-06-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-06-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-06-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-06-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-06-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-06-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-06-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-06-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-06-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-06-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-06-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2023-06-01,0.0,0.0
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-06-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-06-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-06-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-06-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-06-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-06-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-06-01,0.0,0.0
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-06-01,0.0,0.0
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-06-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-06-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-06-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-06-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-06-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-06-01,0.0,0.0
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-06-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-06-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-06-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-06-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-06-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-07-01,820.0,0.01153207886816865
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-07-01,730.0,0.010266362894833066
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-07-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-07-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-07-01,0.0,0.0
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-07-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-07-01,1524.0,0.02143279048181588
m14 [patient services],14.1.8,Outpatient - Dental,2023-07-01,1000.0,0.014063510814839817
m14 [patient services],14.1.9,Outpatient - ENT ,2023-07-01,1003.0,0.014105701347284335
m14 [patient services],14.1.10,Outpatients- Asthma,2023-07-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-07-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-07-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-07-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-07-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-07-01,17.0,0.00023907968385227687
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-07-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-07-01,1375.0,0.019337327370404746
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-07-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-07-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-07-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-07-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-07-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-07-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-07-01,761.0,0.0107023317300931
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-07-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-07-01,20585.0,0.2894973701234776
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-07-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-07-01,138.0,0.0019407644924478945
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-07-01,587.0,0.008255280848310972
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-07-01,99.0,0.0013922875706691418
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-07-01,695.0,0.009774140016313672
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-07-01,140.0,0.0019688915140775743
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-07-01,593.0,0.00833966191320001
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-07-01,101.0,0.0014204145922988214
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-07-01,663.0,0.009324107670238798
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-07-01,9.0,0.00012657159733355834
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-07-01,0.0,0.0
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-07-01,7.0,9.844457570387872e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-07-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-07-01,0.0,0.0
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-07-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-07-01,0.0,0.0
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-07-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-07-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.2,Inpatient - Dengue,2023-07-01,20.0,0.0002812702162967963
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-07-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-07-01,42.0,0.0005906674542232723
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-07-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-07-01,12.0,0.0001687621297780778
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-07-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-07-01,150.0,0.0021095266222259726
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-07-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-07-01,1902.0,0.02674879756982533
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-07-01,455.0,0.006398897420752116
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-07-01,55.0,0.0007734930948161898
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-07-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-07-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-07-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-07-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-07-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-07-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-07-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-07-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-07-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-07-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-07-01,587.0,0.008255280848310972
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-07-01,21.0,0.00029533372711163615
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-07-01,320.0,0.004500323460748741
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-07-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-07-01,62.0,0.0008719376705200685
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-07-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-07-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-07-01,8268.0,0.1162771074170956
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-07-01,41.0,0.0005766039434084325
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-07-01,18.0,0.0002531431946671167
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-07-01,21.0,0.00029533372711163615
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-07-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-07-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-07-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-07-01,5.0,7.031755407419908e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-07-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-07-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-07-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-07-01,5.0,7.031755407419908e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-07-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-07-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-07-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-07-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-07-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-07-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-07-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-07-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-07-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-07-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-07-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-07-01,197.0,0.0027705116305234436
m14 [patient services],14.21,Total number of blood units issued in month,2023-07-01,267.0,0.0037549573875622307
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-07-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-07-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-07-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-07-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-07-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-07-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-07-01,940.0,0.013219700165949427
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-07-01,815.0,0.01146176131409445
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-07-01,11.0,0.00015469861896323797
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-07-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-07-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-07-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-07-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-07-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-07-01,356.0,0.005006609850082975
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-07-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-07-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-07-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-07-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-08-01,929.0,0.013065001546986189
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-08-01,775.0,0.010899220881500858
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-08-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-08-01,276.0,0.003881528984895789
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-08-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-08-01,1447.0,0.020349900149073213
m14 [patient services],14.1.8,Outpatient - Dental,2023-08-01,993.0,0.013965066239135937
m14 [patient services],14.1.9,Outpatient - ENT ,2023-08-01,1074.0,0.015104210615137963
m14 [patient services],14.1.10,Outpatients- Asthma,2023-08-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-08-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-08-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-08-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-08-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-08-01,18.0,0.0002531431946671167
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-08-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-08-01,1150.0,0.016173037437065788
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-08-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-08-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-08-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-08-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-08-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-08-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-08-01,680.0,0.009563187354091075
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-08-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-08-01,21728.0,0.3055719629848395
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-08-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-08-01,184.0,0.002587685989930526
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-08-01,704.0,0.00990071161364723
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-08-01,160.0,0.0022501617303743704
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-08-01,760.0,0.01068826821927826
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-08-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-08-01,163.0,0.00229235226281889
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-08-01,685.0,0.009633504908165273
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-08-01,129.0,0.0018141928951143362
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-08-01,768.0,0.01080077630579698
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-08-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-08-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-08-01,10.0,0.00014063510814839815
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-08-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-08-01,13.0,0.00018282564059291762
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-08-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-08-01,35.0,0.0004922228785193936
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-08-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-08-01,0.0,0.0
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-08-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-08-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.2,Inpatient - Dengue,2023-08-01,34.0,0.00047815936770455374
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-08-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-08-01,68.0,0.0009563187354091075
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-08-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-08-01,11.0,0.00015469861896323797
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-08-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-08-01,119.0,0.0016735577869659382
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-08-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-08-01,1209.0,0.017002784575141337
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-08-01,295.0,0.004148735690377746
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-08-01,45.0,0.0006328579866677918
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-08-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-08-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-08-01,11.0,0.00015469861896323797
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-08-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-08-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-08-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-08-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-08-01,543.0,0.00763648637245802
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-08-01,31.0,0.00043596883526003427
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-08-01,285.0,0.004008100582229348
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-08-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-08-01,55.0,0.0007734930948161898
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-08-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-08-01,9037.0,0.12709194723370743
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-08-01,59.0,0.0008297471380755492
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-08-01,37.0,0.0005203499001490731
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-08-01,10.0,0.00014063510814839815
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-08-01,6.0,8.43810648890389e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-08-01,6.0,8.43810648890389e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-08-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-08-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-08-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-08-01,4.0,5.6254043259359264e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-08-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-08-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-08-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-08-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-08-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-08-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-08-01,4.0,5.6254043259359264e-05
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-08-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-08-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-08-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-08-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-08-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-08-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-08-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-08-01,187.0,0.0026298765223750457
m14 [patient services],14.21,Total number of blood units issued in month,2023-08-01,245.0,0.003445560149635755
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-08-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-08-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-08-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-08-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-08-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-08-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-08-01,960.0,0.013500970382246224
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-08-01,797.0,0.011208618119427333
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-08-01,9.0,0.00012657159733355834
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-08-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-08-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-08-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-08-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-08-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-08-01,738.0,0.010378870981351785
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-08-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-08-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-08-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-08-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-08-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-09-01,875.0,0.012305571962984839
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-09-01,790.0,0.011110173543723454
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-09-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-09-01,229.0,0.003220543976598318
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-09-01,252.0,0.0035440047253396337
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-09-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-09-01,1349.0,0.018971676089218913
m14 [patient services],14.1.8,Outpatient - Dental,2023-09-01,887.0,0.012474334092762917
m14 [patient services],14.1.9,Outpatient - ENT ,2023-09-01,1025.0,0.014415098585210812
m14 [patient services],14.1.10,Outpatients- Asthma,2023-09-01,10.0,0.00014063510814839815
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-09-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-09-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-09-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-09-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-09-01,28.0,0.00039377830281551486
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-09-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-09-01,1110.0,0.015610497004472196
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-09-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-09-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-09-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-09-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-09-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-09-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-09-01,608.0,0.008550614575422609
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-09-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-09-01,20380.0,0.28661435040643546
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-09-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-09-01,104.0,0.001462605124743341
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-09-01,988.0,0.013894748685061738
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-09-01,76.0,0.001068826821927826
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-09-01,793.0,0.011152364076167974
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-09-01,0.0,0.0
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-09-01,114.0,0.001603240232891739
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-09-01,1008.0,0.014176018901358535
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-09-01,81.0,0.001139144376002025
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-09-01,832.0,0.011700840997946728
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-09-01,0.0,0.0
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-09-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-09-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-09-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-09-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-09-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-09-01,6.0,8.43810648890389e-05
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-09-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-09-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-09-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-09-01,30.0,0.0004219053244451945
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-09-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-09-01,237.0,0.0033330520631170363
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-09-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-09-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-09-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-09-01,40.0,0.0005625404325935926
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-09-01,9.0,0.00012657159733355834
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-09-01,50.0,0.0007031755407419908
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-09-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-09-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-09-01,7.0,9.844457570387872e-05
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-09-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-09-01,67.0,0.0009422552245942677
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-09-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-09-01,1807.0,0.025412764042415548
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-09-01,705.0,0.00991477512446207
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-09-01,54.0,0.00075942958400135
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-09-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-09-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-09-01,10.0,0.00014063510814839815
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-09-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-09-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-09-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-09-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-09-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-09-01,508.0,0.007144263493938627
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-09-01,22.0,0.00030939723792647593
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-09-01,828.0,0.011644586954687368
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-09-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-09-01,86.0,0.0012094619300762242
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-09-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-09-01,6.0,8.43810648890389e-05
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-09-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-09-01,8871.0,0.124757404438444
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-09-01,43.0,0.0006047309650381121
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-09-01,24.0,0.0003375242595561556
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-09-01,9.0,0.00012657159733355834
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-09-01,8.0,0.00011250808651871853
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-09-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-09-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-09-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-09-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-09-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-09-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-09-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-09-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-09-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-09-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-09-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-09-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-09-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-09-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-09-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-09-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-09-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-09-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-09-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-09-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2023-09-01,214.0,0.0030095913143757206
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-09-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-09-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-09-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-09-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-09-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-09-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-09-01,944.0,0.013275954209208787
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-09-01,829.0,0.011658650465502208
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-09-01,12.0,0.0001687621297780778
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-09-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-09-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-09-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-09-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-09-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-09-01,480.0,0.006750485191123112
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-09-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-09-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-09-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-09-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-09-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-10-01,860.0,0.012094619300762242
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-10-01,780.0,0.010969538435575056
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-10-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-10-01,254.0,0.0035721317469693133
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-10-01,243.0,0.0034174331280060755
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-10-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-10-01,1330.0,0.018704469383736957
m14 [patient services],14.1.8,Outpatient - Dental,2023-10-01,867.0,0.01219306387646612
m14 [patient services],14.1.9,Outpatient - ENT ,2023-10-01,975.0,0.01371192304446882
m14 [patient services],14.1.10,Outpatients- Asthma,2023-10-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-10-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-10-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-10-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-10-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-10-01,44.0,0.0006187944758529519
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-10-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-10-01,0.0,0.0
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-10-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-10-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-10-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-10-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-10-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-10-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-10-01,669.0,0.009408488735127837
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-10-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-10-01,20934.0,0.2944055353978567
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-10-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-10-01,110.0,0.0015469861896323797
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-10-01,763.0,0.01073045875172278
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-10-01,81.0,0.001139144376002025
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-10-01,685.0,0.009633504908165273
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-10-01,420.0,0.005906674542232723
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-10-01,105.0,0.0014766686355581807
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-10-01,754.0,0.010603887154389221
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-10-01,81.0,0.001139144376002025
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-10-01,673.0,0.009464742778387197
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-10-01,410.0,0.005766039434084325
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-10-01,0.0,0.0
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-10-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-10-01,9.0,0.00012657159733355834
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-10-01,11.0,0.00015469861896323797
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-10-01,8.0,0.00011250808651871853
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-10-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-10-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-10-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-10-01,27.0,0.000379714792000675
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-10-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-10-01,324.0,0.0045565775040081
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-10-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-10-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-10-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-10-01,101.0,0.0014204145922988214
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-10-01,55.0,0.0007734930948161898
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-10-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-10-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-10-01,14.0,0.00019688915140775743
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-10-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-10-01,65.0,0.000914128202964588
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-10-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-10-01,1180.0,0.016594942761510984
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-10-01,883.0,0.012418080049503557
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-10-01,36.0,0.0005062863893342334
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-10-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-10-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-10-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-10-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-10-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-10-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-10-01,383.0,0.00538632464208365
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-10-01,16.0,0.00022501617303743706
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-10-01,313.0,0.004401878885044863
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-10-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-10-01,82.0,0.001153207886816865
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-10-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-10-01,14.0,0.00019688915140775743
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-10-01,14.0,0.00019688915140775743
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-10-01,9258.0,0.13019998312378703
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-10-01,52.0,0.0007313025623716705
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-10-01,28.0,0.00039377830281551486
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-10-01,17.0,0.00023907968385227687
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-10-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-10-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-10-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-10-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-10-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-10-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-10-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-10-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-10-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-10-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-10-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-10-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-10-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-10-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-10-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-10-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-10-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-10-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2023-10-01,214.0,0.0030095913143757206
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-10-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-10-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-10-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-10-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-10-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-10-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-10-01,973.0,0.01368379602283914
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-10-01,841.0,0.011827412595280286
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-10-01,10.0,0.00014063510814839815
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-10-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-10-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-10-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-10-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-10-01,347.0,0.004880038252749416
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-10-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-10-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-10-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-10-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-10-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-11-01,943.0,0.013261890698393947
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-11-01,851.0,0.011968047703428684
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-11-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-11-01,261.0,0.003670576322673192
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-11-01,298.0,0.004190926222822265
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-11-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-11-01,1602.0,0.022529744325373385
m14 [patient services],14.1.8,Outpatient - Dental,2023-11-01,969.0,0.013627541979579782
m14 [patient services],14.1.9,Outpatient - ENT ,2023-11-01,1182.0,0.016623069783140664
m14 [patient services],14.1.10,Outpatients- Asthma,2023-11-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-11-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-11-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-11-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-11-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-11-01,511.0,0.007186454026383146
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-11-01,0.0,0.0
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-11-01,201.0,0.002826765673782803
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-11-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-11-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-11-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-11-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-11-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-11-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-11-01,606.0,0.008522487553792929
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-11-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-11-01,22180.0,0.3119286698731471
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-11-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-11-01,111.0,0.0015610497004472197
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-11-01,889.0,0.012502461114392597
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-11-01,85.0,0.0011953984192613844
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-11-01,970.0,0.013641605490394622
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-11-01,248.0,0.003487750682080274
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-11-01,110.0,0.0015469861896323797
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-11-01,835.0,0.011743031530391246
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-11-01,78.0,0.0010969538435575057
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-11-01,901.0,0.012671223244170674
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-11-01,237.0,0.0033330520631170363
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-11-01,0.0,0.0
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-11-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-11-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-11-01,0.0,0.0
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-11-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-11-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-11-01,14.0,0.00019688915140775743
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-11-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-11-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-11-01,12.0,0.0001687621297780778
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-11-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-11-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-11-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-11-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-11-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-11-01,266.0,0.003740893876747391
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-11-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-11-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-11-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.2,Inpatient - Dengue,2023-11-01,110.0,0.0015469861896323797
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-11-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-11-01,28.0,0.00039377830281551486
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-11-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-11-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-11-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-11-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-11-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-11-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-11-01,2028.0,0.028520799932495147
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-11-01,1380.0,0.019407644924478946
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-11-01,39.0,0.0005484769217787528
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-11-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-11-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-11-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-11-01,6.0,8.43810648890389e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-11-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-11-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-11-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-11-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-11-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-11-01,73.0,0.0010266362894833065
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-11-01,19.0,0.0002672067054819565
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-11-01,0.0,0.0
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-11-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-11-01,88.0,0.0012375889517059037
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-11-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-11-01,8.0,0.00011250808651871853
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-11-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-11-01,10540.0,0.14822940398841167
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-11-01,57.0,0.0008016201164458695
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-11-01,25.0,0.0003515877703709954
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-11-01,24.0,0.0003375242595561556
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-11-01,5.0,7.031755407419908e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-11-01,3.0,4.219053244451945e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-11-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-11-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-11-01,29.0,0.00040784181363035465
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-11-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-11-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-11-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-11-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-11-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-11-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-11-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-11-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-11-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-11-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-11-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-11-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-11-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-11-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-11-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-11-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-11-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-11-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-11-01,270.0,0.0037971479200067503
m14 [patient services],14.21,Total number of blood units issued in month,2023-11-01,270.0,0.0037971479200067503
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-11-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-11-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-11-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-11-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-11-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-11-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-11-01,736.0,0.010350743959722105
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-11-01,661.0,0.009295980648609118
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-11-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-11-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-11-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-11-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-11-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-11-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-11-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-11-01,483.0,0.006792675723567631
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-11-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-11-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-11-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-11-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-11-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2023-12-01,900.0,0.012657159733355834
m14 [patient services],14.1.2,Outpatient - Hypertension,2023-12-01,821.0,0.01154614237898349
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2023-12-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.1.5,Outpatient - Mental illness,2023-12-01,747.0,0.010505442578685343
m14 [patient services],14.1.6,Outpatient - Epilepsy,2023-12-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2023-12-01,2152.0,0.030264675273535283
m14 [patient services],14.1.8,Outpatient - Dental,2023-12-01,1282.0,0.018029420864624644
m14 [patient services],14.1.9,Outpatient - ENT ,2023-12-01,1954.0,0.027480100132197
m14 [patient services],14.1.10,Outpatients- Asthma,2023-12-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2023-12-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2023-12-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2023-12-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2023-12-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2023-12-01,150.0,0.0021095266222259726
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2023-12-01,155.0,0.0021798441763001713
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2023-12-01,1250.0,0.01757938851854977
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2023-12-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2023-12-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2023-12-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2023-12-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2023-12-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2023-12-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2023-12-01,713.0,0.010027283210980788
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2023-12-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2023-12-01,33635.0,0.4730261862571372
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2023-12-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2023-12-01,229.0,0.003220543976598318
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2023-12-01,896.0,0.012600905690096476
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2023-12-01,160.0,0.0022501617303743704
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2023-12-01,823.0,0.01157426940061317
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2023-12-01,354.0,0.004978482828453295
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2023-12-01,210.0,0.0029533372711163615
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2023-12-01,910.0,0.012797794841504232
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2023-12-01,172.0,0.0024189238601524483
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2023-12-01,832.0,0.011700840997946728
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2023-12-01,355.0,0.004992546339268135
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2023-12-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2023-12-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2023-12-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2023-12-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2023-12-01,0.0,0.0
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2023-12-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2023-12-01,0.0,0.0
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2023-12-01,0.0,0.0
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2023-12-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2023-12-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.6,Day Care Admissions,2023-12-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2023-12-01,45.0,0.0006328579866677918
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2023-12-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2023-12-01,277.0,0.003895592495710629
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2023-12-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2023-12-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2023-12-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2023-12-01,110.0,0.0015469861896323797
m14 [patient services],14.4.3,Inpatient - Typhoid,2023-12-01,4.0,5.6254043259359264e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2023-12-01,60.0,0.000843810648890389
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2023-12-01,8.0,0.00011250808651871853
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2023-12-01,15.0,0.00021095266222259724
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2023-12-01,0.0,0.0
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2023-12-01,75.0,0.0010547633111129863
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2023-12-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2023-12-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2023-12-01,2537.0,0.03567912693724861
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2023-12-01,915.0,0.012868112395578432
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2023-12-01,112.0,0.0015751132112620594
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2023-12-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2023-12-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2023-12-01,12.0,0.0001687621297780778
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2023-12-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2023-12-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2023-12-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2023-12-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2023-12-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2023-12-01,462.0,0.006497341996455995
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2023-12-01,14.0,0.00019688915140775743
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2023-12-01,323.0,0.004542513993193261
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2023-12-01,3.0,4.219053244451945e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2023-12-01,148.0,0.0020813996005962926
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2023-12-01,10.0,0.00014063510814839815
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2023-12-01,300.0,0.004219053244451945
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2023-12-01,300.0,0.004219053244451945
m14 [patient services],14.10.,In-Patient Head Count at midnight,2023-12-01,13005.0,0.1828959581469918
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2023-12-01,62.0,0.0008719376705200685
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2023-12-01,40.0,0.0005625404325935926
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2023-12-01,14.0,0.00019688915140775743
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2023-12-01,4.0,5.6254043259359264e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2023-12-01,4.0,5.6254043259359264e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2023-12-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2023-12-01,13.0,0.00018282564059291762
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2023-12-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2023-12-01,3.0,4.219053244451945e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2023-12-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2023-12-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2023-12-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2023-12-01,3.0,4.219053244451945e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2023-12-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2023-12-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2023-12-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2023-12-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2023-12-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2023-12-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2023-12-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2023-12-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2023-12-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2023-12-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2023-12-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2023-12-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2023-12-01,300.0,0.004219053244451945
m14 [patient services],14.21,Total number of blood units issued in month,2023-12-01,300.0,0.004219053244451945
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2023-12-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2023-12-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2023-12-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2023-12-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2023-12-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2023-12-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2023-12-01,967.0,0.013599414957950102
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2023-12-01,866.0,0.01217900036565128
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2023-12-01,13.0,0.00018282564059291762
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2023-12-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2023-12-01,3.0,4.219053244451945e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2023-12-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2023-12-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2023-12-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2023-12-01,502.0,0.0070598824290495875
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2023-12-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2023-12-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2023-12-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2023-12-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2023-12-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-01-01,800.0,0.011250808651871853
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-01-01,701.0,0.009858521081202712
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-01-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-01-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-01-01,878.0,0.012347762495429359
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-01-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-01-01,2516.0,0.035383793210136974
m14 [patient services],14.1.8,Outpatient - Dental,2024-01-01,1367.0,0.01922481928388603
m14 [patient services],14.1.9,Outpatient - ENT ,2024-01-01,2212.0,0.031108485922425672
m14 [patient services],14.1.10,Outpatients- Asthma,2024-01-01,18.0,0.0002531431946671167
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-01-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-01-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-01-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-01-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-01-01,26.0,0.00036565128118583524
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-01-01,350.0,0.004922228785193936
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-01-01,1267.0,0.017818468202402047
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-01-01,4.0,5.6254043259359264e-05
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-01-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-01-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-01-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-01-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-01-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-01-01,774.0,0.010885157370686018
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-01-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-01-01,37897.0,0.5329648693499845
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-01-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-01-01,160.0,0.0022501617303743704
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-01-01,857.0,0.012052428768317722
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-01-01,173.0,0.0024329873709672883
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-01-01,911.0,0.012811858352319072
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-01-01,374.0,0.0052597530447500915
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-01-01,173.0,0.0024329873709672883
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-01-01,851.0,0.011968047703428684
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-01-01,158.0,0.002222034708744691
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-01-01,891.0,0.012530588136022276
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-01-01,374.0,0.0052597530447500915
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-01-01,0.0,0.0
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-01-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-01-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-01-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-01-01,52.0,0.0007313025623716705
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-01-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-01-01,268.0,0.0037690208983770707
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-01-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-01-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-01-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-01-01,65.0,0.000914128202964588
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-01-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-01-01,50.0,0.0007031755407419908
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-01-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-01-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-01-01,25.0,0.0003515877703709954
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-01-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-01-01,101.0,0.0014204145922988214
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-01-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-01-01,1534.0,0.02157342558996428
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-01-01,570.0,0.008016201164458696
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-01-01,110.0,0.0015469861896323797
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-01-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-01-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-01-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-01-01,7.0,9.844457570387872e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-01-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-01-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-01-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-01-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-01-01,3.0,4.219053244451945e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-01-01,442.0,0.006216071780159199
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-01-01,17.0,0.00023907968385227687
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-01-01,293.0,0.004120608668748066
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-01-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-01-01,134.0,0.0018845104491885354
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-01-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-01-01,187.0,0.0026298765223750457
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-01-01,187.0,0.0026298765223750457
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-01-01,12914.0,0.18161617866284138
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-01-01,49.0,0.000689112029927151
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-01-01,26.0,0.00036565128118583524
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-01-01,18.0,0.0002531431946671167
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-01-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-01-01,4.0,5.6254043259359264e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-01-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-01-01,2.0,2.8127021629679632e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-01-01,47.0,0.0006609850082974713
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-01-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-01-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-01-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-01-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-01-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-01-01,1.0,1.4063510814839816e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-01-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-01-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-01-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-01-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-01-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-01-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-01-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-01-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-01-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-01-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-01-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-01-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-01-01,187.0,0.0026298765223750457
m14 [patient services],14.21,Total number of blood units issued in month,2024-01-01,187.0,0.0026298765223750457
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-01-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-01-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-01-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-01-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-01-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-01-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-01-01,9.0,0.00012657159733355834
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-01-01,929.0,0.013065001546986189
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-01-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-01-01,1064.0,0.014963575506989565
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-01-01,3.0,4.219053244451945e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-01-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-01-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-01-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-01-01,434.0,0.00610356369364048
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-01-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-01-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-01-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-01-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-01-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-02-01,750.0,0.010547633111129861
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-02-01,655.0,0.00921159958372008
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-02-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-02-01,907.0,0.012755604309059714
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-02-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-02-01,2452.0,0.03448372851798723
m14 [patient services],14.1.8,Outpatient - Dental,2024-02-01,1562.0,0.021967203892779792
m14 [patient services],14.1.9,Outpatient - ENT ,2024-02-01,2278.0,0.0320366776362051
m14 [patient services],14.1.10,Outpatients- Asthma,2024-02-01,29.0,0.00040784181363035465
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-02-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-02-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-02-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-02-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-02-01,22.0,0.00030939723792647593
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-02-01,398.0,0.005597277304306246
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-02-01,1387.0,0.019506089500182826
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-02-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-02-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-02-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-02-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-02-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-02-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-02-01,768.0,0.01080077630579698
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-02-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-02-01,37385.0,0.5257643518127865
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-02-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-02-01,196.0,0.002756448119708604
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-02-01,799.0,0.011236745141057013
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-02-01,143.0,0.002011082046522094
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-02-01,797.0,0.011208618119427333
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-02-01,388.0,0.005456642196157849
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-02-01,201.0,0.002826765673782803
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-02-01,782.0,0.010997665457204736
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-02-01,151.0,0.002123590133040812
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-02-01,813.0,0.011433634292464771
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-02-01,381.0,0.00535819762045397
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-02-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-02-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-02-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-02-01,7.0,9.844457570387872e-05
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-02-01,6.0,8.43810648890389e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-02-01,8.0,0.00011250808651871853
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-02-01,8.0,0.00011250808651871853
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-02-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-02-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-02-01,48.0,0.0006750485191123112
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-02-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-02-01,252.0,0.0035440047253396337
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-02-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-02-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-02-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-02-01,68.0,0.0009563187354091075
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-02-01,45.0,0.0006328579866677918
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-02-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-02-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-02-01,30.0,0.0004219053244451945
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-02-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-02-01,131.0,0.0018423199167440158
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-02-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-02-01,1390.0,0.019548280032627343
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-02-01,420.0,0.005906674542232723
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-02-01,92.0,0.001293842994965263
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-02-01,0.0,0.0
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-02-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-02-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-02-01,4.0,5.6254043259359264e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-02-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-02-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-02-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-02-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-02-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-02-01,498.0,0.007003628385790228
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-02-01,15.0,0.00021095266222259724
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-02-01,318.0,0.004472196439119062
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-02-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-02-01,130.0,0.001828256405929176
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-02-01,3.0,4.219053244451945e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-02-01,169.0,0.0023767333277079287
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-02-01,169.0,0.0023767333277079287
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-02-01,12268.0,0.17253115067645486
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-02-01,60.0,0.000843810648890389
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-02-01,40.0,0.0005625404325935926
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-02-01,20.0,0.0002812702162967963
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-02-01,4.0,5.6254043259359264e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-02-01,0.0,0.0
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-02-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-02-01,10.0,0.00014063510814839815
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-02-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-02-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-02-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-02-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-02-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-02-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-02-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-02-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-02-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-02-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-02-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-02-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-02-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-02-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-02-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-02-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-02-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-02-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-02-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-02-01,169.0,0.0023767333277079287
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-02-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-02-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-02-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-02-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-02-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-02-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-02-01,0.0,0.0
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-02-01,0.0,0.0
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-02-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-02-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-02-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-02-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-02-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-02-01,382.0,0.00537226113126881
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-02-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-02-01,1.0,1.4063510814839816e-05
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-03-01,630.0,0.008860011813349083
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-03-01,560.0,0.007875566056310297
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-03-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-03-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-03-01,737.0,0.010364807470536945
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-03-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-03-01,2162.0,0.030405310381683683
m14 [patient services],14.1.8,Outpatient - Dental,2024-03-01,1480.0,0.02081399600596293
m14 [patient services],14.1.9,Outpatient - ENT ,2024-03-01,1944.0,0.027339465024048604
m14 [patient services],14.1.10,Outpatients- Asthma,2024-03-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-03-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-03-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-03-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-03-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-03-01,20.0,0.0002812702162967963
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-03-01,328.0,0.00461283154726746
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-03-01,1240.0,0.01743875341040137
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-03-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-03-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-03-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-03-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-03-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-03-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-03-01,707.0,0.00994290214609175
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-03-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-03-01,33539.0,0.4716760892189126
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-03-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-03-01,167.0,0.002348606306078249
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-03-01,701.0,0.009858521081202712
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-03-01,121.0,0.0017016848085956177
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-03-01,743.0,0.010449188535425983
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-03-01,353.0,0.004964419317638455
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-03-01,170.0,0.0023907968385227687
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-03-01,761.0,0.0107023317300931
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-03-01,130.0,0.001828256405929176
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-03-01,791.0,0.011124237054538294
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-03-01,368.0,0.005175371979861052
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-03-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-03-01,0.0,0.0
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-03-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-03-01,0.0,0.0
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-03-01,12.0,0.0001687621297780778
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-03-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-03-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-03-01,7.0,9.844457570387872e-05
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-03-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-03-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-03-01,0.0,0.0
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-03-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-03-01,285.0,0.004008100582229348
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-03-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-03-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.2,Inpatient - Dengue,2024-03-01,25.0,0.0003515877703709954
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-03-01,4.0,5.6254043259359264e-05
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-03-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-03-01,19.0,0.0002672067054819565
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-03-01,5.0,7.031755407419908e-05
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-03-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-03-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-03-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-03-01,2645.0,0.03719798610525131
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-03-01,740.0,0.010406998002981465
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-03-01,83.0,0.0011672713976317048
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-03-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-03-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-03-01,9.0,0.00012657159733355834
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-03-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-03-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-03-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-03-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-03-01,3.0,4.219053244451945e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-03-01,491.0,0.00690518381008635
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-03-01,19.0,0.0002672067054819565
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-03-01,281.0,0.003951846538969989
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-03-01,148.0,0.0020813996005962926
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-03-01,3.0,4.219053244451945e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-03-01,240.0,0.003375242595561556
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-03-01,240.0,0.003375242595561556
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-03-01,11486.0,0.16153348521925012
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-03-01,70.0,0.0009844457570387872
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-03-01,43.0,0.0006047309650381121
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-03-01,20.0,0.0002812702162967963
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-03-01,6.0,8.43810648890389e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-03-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-03-01,14.0,0.00019688915140775743
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-03-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-03-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-03-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-03-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-03-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-03-01,8.0,0.00011250808651871853
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-03-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-03-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-03-01,3.0,4.219053244451945e-05
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-03-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-03-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-03-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-03-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-03-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-03-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-03-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-03-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-03-01,240.0,0.003375242595561556
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-03-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-03-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-03-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-03-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-03-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-03-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-03-01,1011.0,0.014218209433803053
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-03-01,877.0,0.012333698984614519
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-03-01,16.0,0.00022501617303743706
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-03-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-03-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-03-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-03-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-03-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-03-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-03-01,451.0,0.006342643377492757
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-03-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-03-01,1.0,1.4063510814839816e-05
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-03-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-04-01,550.0,0.007734930948161899
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-04-01,480.0,0.006750485191123112
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-04-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-04-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-04-01,285.0,0.004008100582229348
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-04-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-04-01,1320.0,0.018563834275588557
m14 [patient services],14.1.8,Outpatient - Dental,2024-04-01,834.0,0.011728968019576406
m14 [patient services],14.1.9,Outpatient - ENT ,2024-04-01,996.0,0.014007256771580457
m14 [patient services],14.1.10,Outpatients- Asthma,2024-04-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-04-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-04-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-04-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-04-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-04-01,15.0,0.00021095266222259724
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-04-01,363.0,0.005105054425786853
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-04-01,950.0,0.013360335274097825
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-04-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-04-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-04-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-04-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-04-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-04-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-04-01,575.0,0.008086518718532894
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-04-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-04-01,18975.0,0.2668551177115855
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-04-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-04-01,184.0,0.002587685989930526
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-04-01,670.0,0.009422552245942677
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-04-01,134.0,0.0018845104491885354
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-04-01,677.0,0.009520996821646555
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-04-01,336.0,0.004725339633786178
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-04-01,183.0,0.002573622479115686
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-04-01,659.0,0.009267853626979438
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-04-01,125.0,0.001757938851854977
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-04-01,689.0,0.009689758951424633
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-04-01,340.0,0.0047815936770455375
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-04-01,0.0,0.0
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-04-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-04-01,14.0,0.00019688915140775743
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-04-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-04-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-04-01,7.0,9.844457570387872e-05
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-04-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-04-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-04-01,0.0,0.0
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-04-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-04-01,308.0,0.0043315613309706635
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-04-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-04-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-04-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-04-01,19.0,0.0002672067054819565
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-04-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-04-01,0.0,0.0
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-04-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-04-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-04-01,0.0,0.0
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-04-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-04-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-04-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-04-01,1801.0,0.025328382977526508
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-04-01,860.0,0.012094619300762242
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-04-01,78.0,0.0010969538435575057
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-04-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-04-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-04-01,6.0,8.43810648890389e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-04-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-04-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-04-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-04-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-04-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-04-01,417.0,0.005864484009788203
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-04-01,11.0,0.00015469861896323797
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-04-01,294.0,0.004134672179562906
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-04-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-04-01,138.0,0.0019407644924478945
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-04-01,202.0,0.0028408291845976427
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-04-01,0.0,0.0
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-04-01,9057.0,0.1273732174500042
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-04-01,75.0,0.0010547633111129863
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-04-01,44.0,0.0006187944758529519
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-04-01,28.0,0.00039377830281551486
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-04-01,2.0,2.8127021629679632e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-04-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-04-01,1.0,1.4063510814839816e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-04-01,5.0,7.031755407419908e-05
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-04-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-04-01,3.0,4.219053244451945e-05
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-04-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-04-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-04-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-04-01,3.0,4.219053244451945e-05
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-04-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-04-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-04-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-04-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-04-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-04-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-04-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-04-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-04-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-04-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-04-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-04-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-04-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-04-01,202.0,0.0028408291845976427
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-04-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-04-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-04-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-04-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-04-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-04-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-04-01,0.0,0.0
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-04-01,0.0,0.0
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-04-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-04-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-04-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-04-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-04-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-04-01,242.0,0.0034033696171912355
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-04-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-04-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-04-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-04-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-04-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-05-01,570.0,0.008016201164458696
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-05-01,466.0,0.006553596039715354
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-05-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-05-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-05-01,614.0,0.008634995640311647
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-05-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-05-01,2406.0,0.033836807020504595
m14 [patient services],14.1.8,Outpatient - Dental,2024-05-01,1409.0,0.0198154867381093
m14 [patient services],14.1.9,Outpatient - ENT ,2024-05-01,1843.0,0.02591905043174978
m14 [patient services],14.1.10,Outpatients- Asthma,2024-05-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-05-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-05-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-05-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-05-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-05-01,17.0,0.00023907968385227687
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-05-01,334.0,0.004697212612156498
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-05-01,1850.0,0.02601749500745366
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-05-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-05-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-05-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-05-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-05-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-05-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-05-01,707.0,0.00994290214609175
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-05-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-05-01,31547.0,0.44366157567575165
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-05-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-05-01,192.0,0.002700194076449245
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-05-01,874.0,0.012291508452169999
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-05-01,184.0,0.002587685989930526
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-05-01,895.0,0.012586842179281636
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-05-01,461.0,0.006483278485641155
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-05-01,187.0,0.0026298765223750457
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-05-01,814.0,0.011447697803279611
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-05-01,163.0,0.00229235226281889
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-05-01,838.0,0.011785222062835766
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-05-01,429.0,0.006033246139566281
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-05-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-05-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-05-01,0.0,0.0
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-05-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-05-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-05-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-05-01,9.0,0.00012657159733355834
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-05-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-05-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-05-01,9.0,0.00012657159733355834
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-05-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-05-01,8.0,0.00011250808651871853
m14 [patient services],14.3.6,Day Care Admissions,2024-05-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-05-01,0.0,0.0
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-05-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-05-01,357.0,0.005020673360897814
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-05-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-05-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-05-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-05-01,25.0,0.0003515877703709954
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-05-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-05-01,0.0,0.0
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-05-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-05-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-05-01,0.0,0.0
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-05-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-05-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-05-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-05-01,2134.0,0.030011532078868166
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-05-01,935.0,0.013149382611875229
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-05-01,92.0,0.001293842994965263
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-05-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-05-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-05-01,15.0,0.00021095266222259724
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-05-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-05-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-05-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-05-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-05-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-05-01,604.0,0.008494360532163249
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-05-01,19.0,0.0002672067054819565
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-05-01,362.0,0.005090990914972013
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-05-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-05-01,140.0,0.0019688915140775743
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-05-01,200.0,0.002812702162967963
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-05-01,200.0,0.002812702162967963
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-05-01,12413.0,0.17457035974460663
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-05-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-05-01,37.0,0.0005203499001490731
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-05-01,28.0,0.00039377830281551486
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-05-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-05-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-05-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-05-01,3.0,4.219053244451945e-05
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-05-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-05-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-05-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-05-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-05-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-05-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-05-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-05-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-05-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-05-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-05-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-05-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-05-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-05-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-05-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-05-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-05-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-05-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-05-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-05-01,200.0,0.002812702162967963
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-05-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-05-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-05-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-05-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-05-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-05-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-05-01,1161.0,0.016327736056029028
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-05-01,956.0,0.013444716338986864
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-05-01,8.0,0.00011250808651871853
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-05-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-05-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-05-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-05-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-05-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-05-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-05-01,240.0,0.003375242595561556
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-05-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-05-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-05-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-05-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-05-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-06-01,525.0,0.007383343177790903
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-06-01,450.0,0.006328579866677917
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-06-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-06-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-06-01,909.0,0.012783731330689392
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-06-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-06-01,2142.0,0.030124040165386886
m14 [patient services],14.1.8,Outpatient - Dental,2024-06-01,1156.0,0.016257418501954828
m14 [patient services],14.1.9,Outpatient - ENT ,2024-06-01,1780.0,0.02503304925041487
m14 [patient services],14.1.10,Outpatients- Asthma,2024-06-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-06-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-06-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-06-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-06-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-06-01,15.0,0.00021095266222259724
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-06-01,341.0,0.0047956571878603775
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-06-01,1624.0,0.022839141563299862
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-06-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-06-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-06-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-06-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-06-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-06-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-06-01,577.0,0.008114645740162574
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-06-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-06-01,33292.0,0.4682024020476471
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-06-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-06-01,182.0,0.0025595589683008466
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-06-01,857.0,0.012052428768317722
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-06-01,143.0,0.002011082046522094
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-06-01,827.0,0.011630523443872528
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-06-01,465.0,0.006539532528900514
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-06-01,178.0,0.0025033049250414875
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-06-01,866.0,0.01217900036565128
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-06-01,153.0,0.0021517171546704917
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-06-01,835.0,0.011743031530391246
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-06-01,489.0,0.00687705678845667
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-06-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-06-01,9.0,0.00012657159733355834
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-06-01,7.0,9.844457570387872e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-06-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-06-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-06-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-06-01,0.0,0.0
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-06-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-06-01,398.0,0.005597277304306246
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-06-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-06-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-06-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-06-01,82.0,0.001153207886816865
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-06-01,0.0,0.0
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-06-01,9.0,0.00012657159733355834
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-06-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-06-01,6.0,8.43810648890389e-05
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-06-01,24.0,0.0003375242595561556
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-06-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-06-01,0.0,0.0
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-06-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-06-01,2012.0,0.02829578375945771
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-06-01,830.0,0.011672713976317048
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-06-01,91.0,0.0012797794841504233
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-06-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-06-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-06-01,16.0,0.00022501617303743706
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-06-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-06-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-06-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-06-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-06-01,558.0,0.007847439034680617
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-06-01,12.0,0.0001687621297780778
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-06-01,325.0,0.00457064101482294
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-06-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-06-01,130.0,0.001828256405929176
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-06-01,2.0,2.8127021629679632e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-06-01,286.0,0.004022164093044188
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-06-01,286.0,0.004022164093044188
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-06-01,14371.0,0.202106713920063
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-06-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-06-01,0.0,0.0
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-06-01,0.0,0.0
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-06-01,0.0,0.0
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-06-01,0.0,0.0
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-06-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-06-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-06-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-06-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-06-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-06-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-06-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-06-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-06-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-06-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-06-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-06-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-06-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-06-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-06-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-06-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-06-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-06-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-06-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-06-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-06-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-06-01,286.0,0.004022164093044188
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-06-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-06-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-06-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-06-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-06-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-06-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-06-01,1203.0,0.016918403510252297
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-06-01,1068.0,0.015019829550248923
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-06-01,14.0,0.00019688915140775743
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-06-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-06-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-06-01,3.0,4.219053244451945e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-06-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-06-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-06-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-06-01,240.0,0.003375242595561556
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-06-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-06-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-06-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-06-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-06-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-07-01,575.0,0.008086518718532894
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-07-01,480.0,0.006750485191123112
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-07-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-07-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-07-01,1072.0,0.015076083593508283
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-07-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-07-01,2270.0,0.03192416954968638
m14 [patient services],14.1.8,Outpatient - Dental,2024-07-01,1469.0,0.02065929738699969
m14 [patient services],14.1.9,Outpatient - ENT ,2024-07-01,2072.0,0.0291395944083481
m14 [patient services],14.1.10,Outpatients- Asthma,2024-07-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-07-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-07-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-07-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-07-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-07-01,16.0,0.00022501617303743706
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-07-01,355.0,0.004992546339268135
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-07-01,1731.0,0.02434393722048772
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-07-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-07-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-07-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-07-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-07-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-07-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-07-01,911.0,0.012811858352319072
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-07-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-07-01,36697.0,0.5160886563721767
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-07-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-07-01,187.0,0.0026298765223750457
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-07-01,933.0,0.013121255590245549
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-07-01,164.0,0.00230641577363373
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-07-01,857.0,0.012052428768317722
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-07-01,456.0,0.006412960931566956
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-07-01,184.0,0.002587685989930526
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-07-01,954.0,0.013416589317357185
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-07-01,161.0,0.0022642252411892104
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-07-01,858.0,0.012066492279132562
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-07-01,444.0,0.006244198801788879
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-07-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-07-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-07-01,11.0,0.00015469861896323797
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-07-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-07-01,9.0,0.00012657159733355834
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-07-01,0.0,0.0
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-07-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-07-01,30.0,0.0004219053244451945
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-07-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-07-01,261.0,0.003670576322673192
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-07-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-07-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-07-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-07-01,112.0,0.0015751132112620594
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-07-01,29.0,0.00040784181363035465
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-07-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-07-01,0.0,0.0
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-07-01,17.0,0.00023907968385227687
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-07-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-07-01,130.0,0.001828256405929176
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-07-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-07-01,1766.0,0.024836160099007114
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-07-01,650.0,0.00914128202964588
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-07-01,75.0,0.0010547633111129863
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-07-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-07-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-07-01,6.0,8.43810648890389e-05
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-07-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-07-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-07-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-07-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-07-01,1.0,1.4063510814839816e-05
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-07-01,532.0,0.007481787753494782
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-07-01,12.0,0.0001687621297780778
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-07-01,344.0,0.004837847720304897
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-07-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-07-01,120.0,0.001687621297780778
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-07-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-07-01,370.0,0.005203499001490732
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-07-01,370.0,0.005203499001490732
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-07-01,13952.0,0.1962141028886451
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-07-01,56.0,0.0007875566056310297
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-07-01,28.0,0.00039377830281551486
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-07-01,23.0,0.00032346074874131577
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-07-01,2.0,2.8127021629679632e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-07-01,3.0,4.219053244451945e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-07-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-07-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-07-01,42.0,0.0005906674542232723
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-07-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-07-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-07-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-07-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-07-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-07-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-07-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-07-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-07-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-07-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-07-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-07-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-07-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-07-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-07-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-07-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-07-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-07-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-07-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-07-01,370.0,0.005203499001490732
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-07-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-07-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-07-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-07-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-07-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-07-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-07-01,1139.0,0.01601833881810255
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-07-01,985.0,0.013852558152617218
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-07-01,10.0,0.00014063510814839815
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-07-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-07-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-07-01,5.0,7.031755407419908e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-07-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-07-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-07-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-07-01,250.0,0.003515877703709954
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-07-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-07-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-07-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-07-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-07-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-08-01,675.0,0.009492869800016875
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-08-01,520.0,0.007313025623716704
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-08-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-08-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-08-01,809.0,0.011377380249205411
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-08-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-08-01,2197.0,0.030897533260203076
m14 [patient services],14.1.8,Outpatient - Dental,2024-08-01,1399.0,0.019674851629960903
m14 [patient services],14.1.9,Outpatient - ENT ,2024-08-01,1857.0,0.026115939583157537
m14 [patient services],14.1.10,Outpatients- Asthma,2024-08-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-08-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-08-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-08-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-08-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-08-01,18.0,0.0002531431946671167
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-08-01,421.0,0.005920738053047563
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-08-01,1550.0,0.021798441763001716
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-08-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-08-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-08-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-08-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-08-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-08-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-08-01,657.0,0.009239726605349758
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-08-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-08-01,33595.0,0.47246364582454364
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-08-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-08-01,239.0,0.003361179084746716
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-08-01,934.0,0.013135319101060389
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-08-01,202.0,0.0028408291845976427
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-08-01,957.0,0.013458779849801704
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-08-01,428.0,0.006019182628751441
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-08-01,234.0,0.0032908615306725167
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-08-01,952.0,0.013388462295727505
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-08-01,212.0,0.002981464292746041
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-08-01,976.0,0.01372598655528366
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-08-01,433.0,0.00608950018282564
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-08-01,0.0,0.0
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-08-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-08-01,0.0,0.0
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-08-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-08-01,8.0,0.00011250808651871853
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-08-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-08-01,10.0,0.00014063510814839815
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-08-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-08-01,35.0,0.0004922228785193936
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-08-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-08-01,264.0,0.0037127668551177116
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-08-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-08-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-08-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-08-01,170.0,0.0023907968385227687
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-08-01,33.0,0.00046409585688971395
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-08-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-08-01,50.0,0.0007031755407419908
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-08-01,25.0,0.0003515877703709954
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-08-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-08-01,90.0,0.0012657159733355835
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-08-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-08-01,1277.0,0.017959103310550444
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-08-01,550.0,0.007734930948161899
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-08-01,80.0,0.0011250808651871852
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-08-01,1.0,1.4063510814839816e-05
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-08-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-08-01,19.0,0.0002672067054819565
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-08-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-08-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-08-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-08-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-08-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-08-01,492.0,0.006919247320901189
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-08-01,13.0,0.00018282564059291762
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-08-01,298.0,0.004190926222822265
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-08-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-08-01,142.0,0.001997018535707254
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-08-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-08-01,376.0,0.005287880066379771
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-08-01,376.0,0.005287880066379771
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-08-01,13383.0,0.18821196523500125
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-08-01,0.0,0.0
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-08-01,44.0,0.0006187944758529519
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-08-01,29.0,0.00040784181363035465
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-08-01,5.0,7.031755407419908e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-08-01,9.0,0.00012657159733355834
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-08-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-08-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-08-01,6.0,8.43810648890389e-05
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-08-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-08-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-08-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-08-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-08-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-08-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-08-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-08-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-08-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-08-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-08-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-08-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-08-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-08-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-08-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-08-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-08-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-08-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-08-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-08-01,376.0,0.005287880066379771
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-08-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-08-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-08-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-08-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-08-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-08-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-08-01,1118.0,0.015723005090990914
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-08-01,994.0,0.013979129749950777
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-08-01,11.0,0.00015469861896323797
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-08-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-08-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-08-01,3.0,4.219053244451945e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-08-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-08-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-08-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-08-01,168.0,0.002362669816893089
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-08-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-08-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-08-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-08-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-08-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-09-01,655.0,0.00921159958372008
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-09-01,535.0,0.0075239782859393015
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-09-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-09-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-09-01,775.0,0.010899220881500858
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-09-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-09-01,1966.0,0.027648862261975077
m14 [patient services],14.1.8,Outpatient - Dental,2024-09-01,1303.0,0.01832475459173628
m14 [patient services],14.1.9,Outpatient - ENT ,2024-09-01,1786.0,0.02511743031530391
m14 [patient services],14.1.10,Outpatients- Asthma,2024-09-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-09-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-09-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-09-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-09-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-09-01,19.0,0.0002672067054819565
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-09-01,467.0,0.006567659550530194
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-09-01,175.0,0.002461114392596968
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-09-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-09-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-09-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-09-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-09-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-09-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-09-01,657.0,0.009239726605349758
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-09-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-09-01,31966.0,0.44955418670716957
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-09-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-09-01,236.0,0.0033189885523021967
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-09-01,1000.0,0.014063510814839817
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-09-01,209.0,0.0029392737603015215
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-09-01,935.0,0.013149382611875229
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-09-01,245.0,0.003445560149635755
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-09-01,243.0,0.0034174331280060755
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-09-01,885.0,0.012446207071133237
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-09-01,203.0,0.0028548926954124827
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-09-01,1000.0,0.014063510814839817
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-09-01,261.0,0.003670576322673192
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-09-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-09-01,0.0,0.0
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-09-01,13.0,0.00018282564059291762
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-09-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-09-01,0.0,0.0
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-09-01,10.0,0.00014063510814839815
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-09-01,6.0,8.43810648890389e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-09-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-09-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-09-01,30.0,0.0004219053244451945
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-09-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-09-01,314.0,0.004415942395859703
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-09-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-09-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.4.2,Inpatient - Dengue,2024-09-01,165.0,0.0023204792844485696
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-09-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-09-01,44.0,0.0006187944758529519
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-09-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-09-01,35.0,0.0004922228785193936
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-09-01,10.0,0.00014063510814839815
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-09-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-09-01,87.0,0.001223525440891064
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-09-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-09-01,1262.0,0.017748150648327847
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-09-01,350.0,0.004922228785193936
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-09-01,75.0,0.0010547633111129863
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-09-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-09-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-09-01,12.0,0.0001687621297780778
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-09-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-09-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-09-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-09-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-09-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-09-01,379.0,0.005330070598824291
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-09-01,8.0,0.00011250808651871853
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-09-01,256.0,0.003600258768598993
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-09-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-09-01,144.0,0.0020251455573369334
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-09-01,5.0,7.031755407419908e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-09-01,366.0,0.005147244958231372
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-09-01,366.0,0.005147244958231372
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-09-01,12767.0,0.17954884257305992
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-09-01,71.0,0.000998509267853627
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-09-01,41.0,0.0005766039434084325
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-09-01,19.0,0.0002672067054819565
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-09-01,8.0,0.00011250808651871853
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-09-01,3.0,4.219053244451945e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-09-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-09-01,2.0,2.8127021629679632e-05
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-09-01,5.0,7.031755407419908e-05
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-09-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-09-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-09-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-09-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-09-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-09-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-09-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-09-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-09-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-09-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-09-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-09-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-09-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-09-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-09-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-09-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-09-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-09-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-09-01,0.0,0.0
m14 [patient services],14.21,Total number of blood units issued in month,2024-09-01,366.0,0.005147244958231372
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-09-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-09-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-09-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-09-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-09-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-09-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-09-01,1032.0,0.01451354316091469
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-09-01,926.0,0.01302281101454167
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-09-01,8.0,0.00011250808651871853
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-09-01,0.0,0.0
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-09-01,0.0,0.0
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-09-01,5.0,7.031755407419908e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-09-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-09-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-09-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-09-01,0.0,0.0
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-09-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-09-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-09-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-09-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-09-01,0.0,0.0
m14 [patient services],14.1.1,Outpatient - Diabetes,2024-10-01,630.0,0.008860011813349083
m14 [patient services],14.1.2,Outpatient - Hypertension,2024-10-01,520.0,0.007313025623716704
m14 [patient services],14.1.3,Outpatient - Stroke (Paralysis),2024-10-01,0.0,0.0
m14 [patient services],14.1.4,Outpatient - Cardiovascular Disease,2024-10-01,0.0,0.0
m14 [patient services],14.1.5,Outpatient - Mental illness,2024-10-01,696.0,0.009788203527128512
m14 [patient services],14.1.6,Outpatient - Epilepsy,2024-10-01,0.0,0.0
m14 [patient services],14.1.7,Outpatient - Ophthalmic Related,2024-10-01,1885.0,0.026509717885973054
m14 [patient services],14.1.8,Outpatient - Dental,2024-10-01,1369.0,0.019252946305515706
m14 [patient services],14.1.9,Outpatient - ENT ,2024-10-01,1932.0,0.027170702894270524
m14 [patient services],14.1.10,Outpatients- Asthma,2024-10-01,0.0,0.0
m14 [patient services],14.1.11,Outpatient - Oral Cancer,2024-10-01,0.0,0.0
m14 [patient services],14.1.12,Outpatient - Breast Cancer,2024-10-01,0.0,0.0
m14 [patient services],14.1.13,Outpatient - Cervical Cancer,2024-10-01,0.0,0.0
m14 [patient services],14.1.14,Outpatient - Other Cancer,2024-10-01,0.0,0.0
m14 [patient services],14.1.15,Outpatient - COPD,2024-10-01,20.0,0.0002812702162967963
m14 [patient services],14.1.16,Outpatient - CKD (Chronic Kidney Disease),2024-10-01,392.0,0.005512896239417208
m14 [patient services],14.1.17,Outpatient- Patients undergoing refraction,2024-10-01,1100.0,0.015469861896323798
m14 [patient services],14.1.18,Outpatient - Tuberculosis,2024-10-01,0.0,0.0
m14 [patient services],14.1.19,Outpatient - Leprosy Cases,2024-10-01,0.0,0.0
m14 [patient services],14.1.20,Outpatient - Leprosy with Grade II disability ,2024-10-01,0.0,0.0
m14 [patient services],14.1.21,Outpatient - Geriatric (age>=60 yrs),2024-10-01,0.0,0.0
m14 [patient services],14.1.22,Outpatient - Chronic Liver Disease,2024-10-01,0.0,0.0
m14 [patient services],14.1.23,Outpatient - Palliative Care,2024-10-01,0.0,0.0
m14 [patient services],14.1.24.a,Number of patients provided physiotherapy services,2024-10-01,690.0,0.009703822462239473
m14 [patient services],14.1.24.b,Number of Palliative Patients visited at home ,2024-10-01,0.0,0.0
m14 [patient services],14.2.1,Allopathic- Outpatient attendance,2024-10-01,31010.0,0.4361094703681827
m14 [patient services],14.2.2,Ayush - Outpatient attendance,2024-10-01,0.0,0.0
m14 [patient services],14.3.1.a,IPD Admission Male- Children<18yrs,2024-10-01,253.0,0.0035580682361544733
m14 [patient services],14.3.1.b,IPD Admission Male- Adults <60yrs,2024-10-01,1025.0,0.014415098585210812
m14 [patient services],14.3.1.c,IPD Admission Female- Children<18yrs,2024-10-01,205.0,0.0028830197170421623
m14 [patient services],14.3.1.d,IPD Admission Female- Adults<60yrs,2024-10-01,1070.0,0.015047956571878603
m14 [patient services],14.3.1.e,IPD Admission Geriatric->=60yrs,2024-10-01,384.0,0.00540038815289849
m14 [patient services],14.3.2.a,IPD Discharge Male- Children<18yrs,2024-10-01,253.0,0.0035580682361544733
m14 [patient services],14.3.2.b,IPD Discharge Male- Adults<60yrs,2024-10-01,972.0,0.013669732512024302
m14 [patient services],14.3.2.c,IPD Discharge Female- Children<18yrs,2024-10-01,202.0,0.0028408291845976427
m14 [patient services],14.3.2.d,IPD Discharge Female- Adults<60yrs,2024-10-01,1015.0,0.014274463477062413
m14 [patient services],14.3.2.e,IPD Discharge Geriatric->=60yrs,2024-10-01,399.0,0.005611340815121086
m14 [patient services],14.3.3.a,IPD Referred Male- Children<18yrs,2024-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.3.b,IPD Referred Male- Adults<60yrs,2024-10-01,4.0,5.6254043259359264e-05
m14 [patient services],14.3.3.c,IPD Referred Female- Children<18yrs,2024-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.d,IPD Referred Female- Adults<60yrs,2024-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.3.e,IPD Referred Geriatric->=60yrs,2024-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.3.4.a,IPD Deaths Male- Children<18yrs,2024-10-01,0.0,0.0
m14 [patient services],14.3.4.b,IPD Deaths Male- Adults<60yrs,2024-10-01,9.0,0.00012657159733355834
m14 [patient services],14.3.4.c,IPD Deaths Female- Children<18yrs,2024-10-01,0.0,0.0
m14 [patient services],14.3.4.d,IPD Deaths Female- Adults<60yrs,2024-10-01,5.0,7.031755407419908e-05
m14 [patient services],14.3.4.e,IPD Deaths Geriatric->=60yrs,2024-10-01,14.0,0.00019688915140775743
m14 [patient services],14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,2024-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM),2024-10-01,3.0,4.219053244451945e-05
m14 [patient services],14.3.6,Day Care Admissions,2024-10-01,0.0,0.0
m14 [patient services],14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility,2024-10-01,25.0,0.0003515877703709954
m14 [patient services],14.3.7.b,Number of delivery LAMA cases reported at the facility,2024-10-01,0.0,0.0
m14 [patient services],14.3.8,Total number of Medico Legal Cases reported at the facility,2024-10-01,341.0,0.0047956571878603775
m14 [patient services],14.3.9,Total number of postmortem conducted at the facility,2024-10-01,0.0,0.0
m14 [patient services],14.3.10,Total number of telemedicine consultation provided,2024-10-01,0.0,0.0
m14 [patient services],14.4.1,Inpatient - Malaria ,2024-10-01,0.0,0.0
m14 [patient services],14.4.2,Inpatient - Dengue,2024-10-01,60.0,0.000843810648890389
m14 [patient services],14.4.3,Inpatient - Typhoid,2024-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.4.4,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections",2024-10-01,41.0,0.0005766039434084325
m14 [patient services],14.4.5,Inpatient - Tuberculosis,2024-10-01,0.0,0.0
m14 [patient services],14.4.6,Inpatient - Pyrexia of unknown origin (PUO),2024-10-01,28.0,0.00039377830281551486
m14 [patient services],14.4.7,Inpatient - Diarrhoea with dehydration,2024-10-01,10.0,0.00014063510814839815
m14 [patient services],14.4.8,Inpatient - Leprosy (Reconstructive Surgery),2024-10-01,0.0,0.0
m14 [patient services],14.4.9,Inpatient - Operated for Cataract,2024-10-01,94.0,0.0013219700165949427
m14 [patient services],14.4.10,Inpatient - Pallative Care,2024-10-01,0.0,0.0
m14 [patient services],14.5.1,Patients registered at Emergency Department,2024-10-01,1327.0,0.018662278851292437
m14 [patient services],14.5.2,No. of Emergencies managed at night (8 PM- 8 AM),2024-10-01,510.0,0.007172390515568306
m14 [patient services],14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission",2024-10-01,110.0,0.0015469861896323797
m14 [patient services],14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths",2024-10-01,4.0,5.6254043259359264e-05
m14 [patient services],14.6.2.a,Emergency - Burn -Admission,2024-10-01,0.0,0.0
m14 [patient services],14.6.2.b,Emergency - Burn -Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.6.3.a,Emergency - Obstetrics complications -Admission,2024-10-01,0.0,0.0
m14 [patient services],14.6.3.b,Emergency - Obstetrics complications -Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.6.4.a,Emergency - Snake Bite -Admission,2024-10-01,12.0,0.0001687621297780778
m14 [patient services],14.6.4.b,Emergency - Snake Bite -Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.6.5.a,Emergency - Acute Cardiac Emergencies - Admission,2024-10-01,0.0,0.0
m14 [patient services],14.6.5.b,Emergency - Acute Cardiac Emergencies - Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission,2024-10-01,0.0,0.0
m14 [patient services],14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.6.7.a,Emergency - Dog Bite - Admission,2024-10-01,0.0,0.0
m14 [patient services],14.6.7.b,Emergency - Dog Bite - Deaths,2024-10-01,0.0,0.0
m14 [patient services],14.7,Total number of deaths occurring at Emergency Department,2024-10-01,0.0,0.0
m14 [patient services],14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia),2024-10-01,435.0,0.00611762720445532
m14 [patient services],14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries",2024-10-01,10.0,0.00014063510814839815
m14 [patient services],14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology.",2024-10-01,296.0,0.004162799201192585
m14 [patient services],14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,2024-10-01,0.0,0.0
m14 [patient services],14.8.2,Minor Operations (No or local anaesthesia),2024-10-01,143.0,0.002011082046522094
m14 [patient services],14.8.3,Number of post operative Surgical Site infection,2024-10-01,4.0,5.6254043259359264e-05
m14 [patient services],14.9.1,Number of blood units issued for Operations (excluding C-section),2024-10-01,15.0,0.00021095266222259724
m14 [patient services],14.9.2,Number of blood transfusions done during Operations (excluding C-section),2024-10-01,15.0,0.00021095266222259724
m14 [patient services],14.10.,In-Patient Head Count at midnight,2024-10-01,15032.0,0.2114026945686721
m14 [patient services],14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit),2024-10-01,74.0,0.0010406998002981463
m14 [patient services],14.11.2,Special Newborn Care Unit (SNCU Admissions) - Inborn Male,2024-10-01,51.0,0.0007172390515568306
m14 [patient services],14.11.3,Special Newborn Care Unit (SNCU Admissions) - Inborn Female,2024-10-01,23.0,0.00032346074874131577
m14 [patient services],14.11.4,Special Newborn Care Unit (SNCU Admissions) - Outborn Male,2024-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.5,Special Newborn Care Unit (SNCU Admissions) - Outborn Female,2024-10-01,1.0,1.4063510814839816e-05
m14 [patient services],14.11.6,Special Newborn Care Unit (SNCU Admissions) - referred by ASHA,2024-10-01,0.0,0.0
m14 [patient services],14.12.1,Number of deaths occurred at SNCU,2024-10-01,0.0,0.0
m14 [patient services],14.12.2,Number of Newborns successfully discharged from SNCU,2024-10-01,9.0,0.00012657159733355834
m14 [patient services],14.13.1.a,Total number of PW and PNC - JSSK Beneficiaries,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.b,Number of PW and PNC benificiaries provided - Free Medicines under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.c,Number of PW and PNC benificiaries provided - Free Diet under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.d,Number of PW and PNC benificiaries provided - Free Diagnostics under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.e,Number of PW and PNC benificiaries provided - Free Home to facility transport under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.f,Number of PW and PNC benificiaries provided - Interfacility transfers when needed under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.g,Number of PW and PNC benificiaries provided - Free Drop Back home under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.1.h,Number of PW and PNC benificiaries provided - Free Blood transfusion under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.b,Number of sick infants provided - Free Medicines under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.e,Number of sick infants provided - Interfacility transfers when needed under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.f,Number of sick infants provided - Free Drop Back home under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.13.2.g,Number of sick infants provided - Free Blood transfusion under JSSK,2024-10-01,0.0,0.0
m14 [patient services],14.14.1,Number of sick SAM children admitted in standalone/ integrated NRC ,2024-10-01,0.0,0.0
m14 [patient services],14.14.2,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM),2024-10-01,0.0,0.0
m14 [patient services],14.14.3,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC),2024-10-01,0.0,0.0
m14 [patient services],14.14.4,Number of children Referred to standalone/ integrated NRC by RBSK Team,2024-10-01,0.0,0.0
m14 [patient services],14.14.5,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria,2024-10-01,0.0,0.0
m14 [patient services],14.14.6,Number of admitted children left against medical advice (LAMA) / defaulter,2024-10-01,0.0,0.0
m14 [patient services],14.14.7,Number of children died while admitted in standalone/ intergrated NRC,2024-10-01,0.0,0.0
m14 [patient services],14.14.8,Number of children who completed all four post discharge follow-ups ,2024-10-01,0.0,0.0
m14 [patient services],14.14.9,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC),2024-10-01,0.0,0.0
m14 [patient services],14.14.10,In-Patient Head Count at midnight for standalone/ integrated NRC,2024-10-01,0.0,0.0
m14 [patient services],14.15.1,Number of Rogi Kalyan Samiti (RKS) meetings held,2024-10-01,0.0,0.0
m14 [patient services],14.15.2,Number of Jan Arogya Samiti (JAS) meetings held,2024-10-01,0.0,0.0
m14 [patient services],14.16,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions,2024-10-01,0.0,0.0
m14 [patient services],14.17,Total number of UHND/VHND sessions conducted in the reporting month,2024-10-01,0.0,0.0
m14 [patient services],14.18,Total number of Outreach/Special Outreach camps conducted in the reporting month,2024-10-01,0.0,0.0
m14 [patient services],14.19.a,Stock out rate of essential Drugs,2024-10-01,0.0,0.0
m14 [patient services],14.19.b,Total no. of essential drugs for which stock-outs reported ,2024-10-01,0.0,0.0
m14 [patient services],14.2,Blood Units Issued on replacement -{Any donor (apart from voluntary blood donor) to be considered as replacement donations},2024-10-01,150.0,0.0021095266222259726
m14 [patient services],14.21,Total number of blood units issued in month,2024-10-01,316.0,0.004444069417489382
m14 [patient services],14.22,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal),2024-10-01,0.0,0.0
m14 [patient services],14.23.1.a,Number of patients registered for hemodialysis services in the centre during the reporting month ,2024-10-01,0.0,0.0
m14 [patient services],14.23.1.b,Number of patients on waiting list for hemodialysis services at the end of reporting month,2024-10-01,0.0,0.0
m14 [patient services],14.23.1.c,Number of hemodialysis sessions held during the reporting month,2024-10-01,0.0,0.0
m14 [patient services],14.23.2.a,Number of patients started Peritoneal dialysis under PMNDP during the reporting month ,2024-10-01,0.0,0.0
m14 [patient services],14.24.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV),2024-10-01,0.0,0.0
m14 [patient services],14.24.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women),2024-10-01,1074.0,0.015104210615137963
m14 [patient services],14.24.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV),2024-10-01,946.0,0.013304081230838465
m14 [patient services],14.24.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,2024-10-01,7.0,9.844457570387872e-05
m14 [patient services],14.24.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,2024-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV),2024-10-01,2.0,2.8127021629679632e-05
m14 [patient services],14.24.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment,2024-10-01,0.0,0.0
m14 [patient services],14.24.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12),2024-10-01,0.0,0.0
m14 [patient services],14.24.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,2024-10-01,0.0,0.0
m14 [patient services],14.24.3.a,Number of Pregnant Women tested for HBsAg,2024-10-01,0.0,0.0
m14 [patient services],14.24.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg),2024-10-01,0.0,0.0
m14 [patient services],14.24.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery,2024-10-01,0.0,0.0
m14 [patient services],14.24.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution,2024-10-01,0.0,0.0
m14 [patient services],14.24.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women,2024-10-01,0.0,0.0
m14 [patient services],14.24.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth),2024-10-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-04-01,34769.0,0.48897420752116555
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-04-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-04-01,2316.0,0.032571091047169015
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-04-01,16.0,0.00022501617303743706
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-04-01,430.0,0.006047309650381121
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-04-01,455.0,0.006398897420752116
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-04-01,62.0,0.0008719376705200685
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-04-01,204.0,0.0028689562062273223
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-04-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-04-01,44.0,0.0006187944758529519
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-04-01,2639.0,0.03711360504036228
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-04-01,1130.0,0.01589176722076899
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-04-01,333.0,0.004683149101341658
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-04-01,320.0,0.004500323460748741
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-04-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-05-01,41196.0,0.579360391528141
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-05-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-05-01,3256.0,0.045790791213118444
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-05-01,21.0,0.00029533372711163615
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-05-01,385.0,0.005414451663713329
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-05-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-05-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-05-01,506.0,0.007116136472308947
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-05-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-05-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-05-01,70.0,0.0009844457570387872
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-05-01,158.0,0.002222034708744691
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-05-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-05-01,49.0,0.000689112029927151
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-05-01,2728.0,0.03836525750288302
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-05-01,1291.0,0.018155992461958204
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-05-01,390.0,0.005484769217787528
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-05-01,400.0,0.005625404325935926
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-05-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-06-01,40798.0,0.5737631142238349
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-06-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-06-01,3146.0,0.044243805023486064
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-06-01,21.0,0.00029533372711163615
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-06-01,441.0,0.006202008269344359
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-06-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-06-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-06-01,534.0,0.0075099147751244615
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-06-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-06-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-06-01,66.0,0.0009281917137794279
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-06-01,209.0,0.0029392737603015215
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-06-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-06-01,82.0,0.001153207886816865
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-06-01,3017.0,0.04242961212837172
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-06-01,1377.0,0.019365454392034426
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-06-01,390.0,0.005484769217787528
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-06-01,415.0,0.005836356988158524
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-06-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-07-01,42062.0,0.5915393918937923
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-07-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-07-01,3645.0,0.05126149692009113
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-07-01,645.0,0.009070964475571682
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-07-01,452.0,0.006356706888307597
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-07-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-07-01,551.0,0.007748994458976739
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-07-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-07-01,89.0,0.0012516524625207437
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-07-01,185.0,0.002601749500745366
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-07-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-07-01,53.0,0.0007453660731865103
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-07-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-07-01,3024.0,0.042528056704075605
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-07-01,1418.0,0.01994205833544286
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-07-01,362.0,0.005090990914972013
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-07-01,450.0,0.006328579866677917
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-07-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-08-01,44726.0,0.6290045847045256
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-08-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-08-01,3648.0,0.05130368745253565
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-08-01,29.0,0.00040784181363035465
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-08-01,399.0,0.005611340815121086
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-08-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-08-01,479.0,0.006736421680308272
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-08-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-08-01,56.0,0.0007875566056310297
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-08-01,226.0,0.0031783534441537985
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-08-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-08-01,121.0,0.0017016848085956177
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-08-01,11.0,0.00015469861896323797
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-08-01,2858.0,0.04019351390881219
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-08-01,1433.0,0.020153010997665456
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-08-01,202.0,0.0028408291845976427
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-08-01,501.0,0.0070458189182347475
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-08-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-09-01,45900.0,0.6455151464011476
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-09-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-09-01,4371.0,0.061471605771664835
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-09-01,28.0,0.00039377830281551486
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-09-01,404.0,0.0056816583691952855
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-09-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-09-01,656.0,0.00922566309453492
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-09-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-09-01,86.0,0.0012094619300762242
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-09-01,211.0,0.002967400781931201
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-09-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-09-01,146.0,0.002053272578966613
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-09-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-09-01,2974.0,0.04182488116333361
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-09-01,1408.0,0.01980142322729446
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-09-01,41.0,0.0005766039434084325
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-09-01,725.0,0.010196045340758866
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-09-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-10-01,46883.0,0.6593395775321351
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-10-01,6.0,8.43810648890389e-05
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-10-01,4657.0,0.06549376986470902
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-10-01,21.0,0.00029533372711163615
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-10-01,377.0,0.005301943577194611
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-10-01,64.0,0.0009000646921497482
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-10-01,540.0,0.007594295840013501
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-10-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-10-01,347.0,0.004880038252749416
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-10-01,44.0,0.0006187944758529519
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-10-01,223.0,0.003136162911709279
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-10-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-10-01,181.0,0.0025454954574860066
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-10-01,16.0,0.00022501617303743706
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-10-01,3251.0,0.04572047365904424
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-10-01,1297.0,0.01824037352684724
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-10-01,353.0,0.004964419317638455
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-10-01,809.0,0.011377380249205411
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-10-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-11-01,45663.0,0.6421820943380305
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-11-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-11-01,3910.0,0.05498832728602368
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-11-01,67.0,0.0009422552245942677
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-11-01,318.0,0.004472196439119062
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-11-01,8.0,0.00011250808651871853
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-11-01,532.0,0.007481787753494782
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-11-01,5.0,7.031755407419908e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-11-01,483.0,0.006792675723567631
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-11-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-11-01,195.0,0.002742384608893764
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-11-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-11-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-11-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-11-01,2881.0,0.04051697465755351
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-11-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-11-01,1442.0,0.020279582594999016
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-11-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-11-01,359.0,0.005048800382527494
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-11-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-11-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-11-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-11-01,612.0,0.008606868618681967
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-11-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2023-12-01,45015.0,0.6330689393300143
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2023-12-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2023-12-01,3938.0,0.055382105588839194
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2023-12-01,64.0,0.0009000646921497482
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-12-01,435.0,0.00611762720445532
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2023-12-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-12-01,502.0,0.0070598824290495875
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-12-01,528.0,0.007425533710235423
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2023-12-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-12-01,42.0,0.0005906674542232723
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-12-01,238.0,0.0033471155739318763
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2023-12-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2023-12-01,95.0,0.0013360335274097824
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2023-12-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2023-12-01,3197.0,0.044961044075042894
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2023-12-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2023-12-01,1310.0,0.01842319916744016
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2023-12-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2023-12-01,419.0,0.005892611031417883
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2023-12-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2023-12-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2023-12-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2023-12-01,700.0,0.009844457570387872
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2023-12-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-01-01,45403.0,0.6385255815261721
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-01-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-01-01,3619.0,0.05089584563890529
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-01-01,17.0,0.00023907968385227687
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-01-01,460.0,0.006469214974826315
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-01-01,7.0,9.844457570387872e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-01-01,591.0,0.008311534891570332
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-01-01,5.0,7.031755407419908e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-01-01,434.0,0.00610356369364048
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-01-01,39.0,0.0005484769217787528
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-01-01,269.0,0.0037830844091919103
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-01-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-01-01,124.0,0.001743875341040137
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-01-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-01-01,2986.0,0.04199364329311169
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-01-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-01-01,1361.0,0.01914043821899699
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-01-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-01-01,368.0,0.005175371979861052
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-01-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-01-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-01-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-01-01,800.0,0.011250808651871853
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-01-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-02-01,57804.0,0.8129271791410008
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-02-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-02-01,4939.0,0.06945967991449385
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-02-01,22.0,0.00030939723792647593
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-02-01,534.0,0.0075099147751244615
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-02-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-02-01,637.0,0.008958456389052964
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-02-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-02-01,382.0,0.00537226113126881
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-02-01,6.0,8.43810648890389e-05
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-02-01,278.0,0.003909656006525469
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-02-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-02-01,113.0,0.0015891767220768992
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-02-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-02-01,2995.0,0.04212021489044525
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-02-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-02-01,1299.0,0.01826850054847692
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-02-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-02-01,444.0,0.006244198801788879
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-02-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-02-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-02-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-02-01,1016.0,0.014288526987877253
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-02-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-03-01,55790.0,0.7846032683599133
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-03-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-03-01,3982.0,0.05600090006469215
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-03-01,10.0,0.00014063510814839815
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-03-01,415.0,0.005836356988158524
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-03-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-03-01,601.0,0.008452169999718729
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-03-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-03-01,451.0,0.006342643377492757
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-03-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-03-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-03-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-03-01,52.0,0.0007313025623716705
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-03-01,8.0,0.00011250808651871853
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-03-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-03-01,255.0,0.003586195257784153
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-03-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-03-01,70.0,0.0009844457570387872
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-03-01,6.0,8.43810648890389e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-03-01,2863.0,0.040263831462886396
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-03-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-03-01,1324.0,0.018620088318847917
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-03-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-03-01,476.0,0.006694231147863753
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-03-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-03-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-03-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-03-01,963.0,0.013543160914690744
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-03-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-04-01,52033.0,0.7317666582285601
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-04-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-04-01,3595.0,0.05055832137934914
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-04-01,23.0,0.00032346074874131577
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-04-01,393.0,0.005526959750232048
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-04-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-04-01,610.0,0.008578741597052287
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-04-01,10.0,0.00014063510814839815
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-04-01,236.0,0.0033189885523021967
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-04-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-04-01,78.0,0.0010969538435575057
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-04-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-04-01,2775.0,0.03902624251118049
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-04-01,1202.0,0.016904339999437457
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-04-01,489.0,0.00687705678845667
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-04-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-04-01,1090.0,0.0153292267881754
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-04-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-05-01,61943.0,0.8711360504036227
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-05-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-05-01,4512.0,0.06345456079655724
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-05-01,25.0,0.0003515877703709954
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-05-01,469.0,0.0065957865721598735
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-05-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-05-01,682.0,0.009591314375720755
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-05-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-05-01,15.0,0.00021095266222259724
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-05-01,262.0,0.0036846398334880316
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-05-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-05-01,60.0,0.000843810648890389
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-05-01,3062.0,0.04306247011503952
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-05-01,1437.0,0.020209265040924816
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-05-01,541.0,0.007608359350828341
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-05-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-05-01,989.0,0.013908812195876578
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-05-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-06-01,66280.0,0.9321294968075831
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-06-01,200.0,0.002812702162967963
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-06-01,6402.0,0.09003459623660451
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-06-01,23.0,0.00032346074874131577
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-06-01,535.0,0.0075239782859393015
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-06-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-06-01,585.0,0.008227153826681292
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-06-01,3.0,4.219053244451945e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-06-01,8.0,0.00011250808651871853
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-06-01,308.0,0.0043315613309706635
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-06-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-06-01,108.0,0.0015188591680027
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-06-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-06-01,2938.0,0.04131859477399938
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-06-01,1365.0,0.01919669226225635
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-06-01,500.0,0.007031755407419908
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-06-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-06-01,688.0,0.009675695440609793
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-06-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-07-01,71106.0,1.0
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-07-01,0.0,0.0
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-07-01,5539.0,0.07789778640339774
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-07-01,23.0,0.00032346074874131577
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-07-01,430.0,0.006047309650381121
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-07-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-07-01,583.0,0.008199026805051612
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-07-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-07-01,15.0,0.00021095266222259724
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-07-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-07-01,218.0,0.0030658453576350797
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-07-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-07-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-07-01,126.0,0.0017720023626698169
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-07-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-07-01,3165.0,0.04451101172896802
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-07-01,1589.0,0.02234691868478047
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-07-01,498.0,0.007003628385790228
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-07-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-07-01,1527.0,0.0214749810142604
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-07-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-08-01,68323.0,0.9608612494023008
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-08-01,4.0,5.6254043259359264e-05
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-08-01,5713.0,0.08034483728517987
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-08-01,16.0,0.00022501617303743706
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-08-01,469.0,0.0065957865721598735
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-08-01,7.0,9.844457570387872e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-08-01,546.0,0.00767867690490254
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-08-01,8.0,0.00011250808651871853
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-08-01,168.0,0.002362669816893089
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-08-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-08-01,20.0,0.0002812702162967963
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-08-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-08-01,276.0,0.003881528984895789
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-08-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-08-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-08-01,174.0,0.002447050881782128
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-08-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-08-01,3036.0,0.04269681883385368
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-08-01,1477.0,0.02077180547351841
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-08-01,473.0,0.006652040615419233
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-08-01,189.0,0.0026580035440047253
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-08-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-08-01,967.0,0.013599414957950102
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-08-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-09-01,66838.0,0.9399769358422636
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-09-01,13.0,0.00018282564059291762
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-09-01,5773.0,0.08118864793407025
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-09-01,14.0,0.00019688915140775743
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-09-01,453.0,0.006370770399122437
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-09-01,5.0,7.031755407419908e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-09-01,613.0,0.008620932129496807
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-09-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-09-01,32.0,0.0004500323460748741
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-09-01,266.0,0.003740893876747391
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-09-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-09-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-09-01,165.0,0.0023204792844485696
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-09-01,1.0,1.4063510814839816e-05
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-09-01,3223.0,0.04532669535622873
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-09-01,1408.0,0.01980142322729446
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-09-01,475.0,0.006680167637048913
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-09-01,160.0,0.0022501617303743704
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-09-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-09-01,789.0,0.011096110032908614
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-09-01,0.0,0.0
m15 [laboratory testing],15.1.1,Total Number of Lab Tests done- Inhouse,2024-10-01,63969.0,0.8996287233144882
m15 [laboratory testing],15.1.2,Total Number of Lab Tests done- Outsourced,2024-10-01,30.0,0.0004219053244451945
m15 [laboratory testing],15.2.1,Number of Hb tests conducted including kit tests,2024-10-01,4936.0,0.06941748938204934
m15 [laboratory testing],15.2.2,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",2024-10-01,22.0,0.00030939723792647593
m15 [laboratory testing],15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-10-01,415.0,0.005836356988158524
m15 [laboratory testing],15.3.1.b,"Out of the above, No. of males found reactive for HIV",2024-10-01,2.0,2.8127021629679632e-05
m15 [laboratory testing],15.3.1.c,Number of HIV reactive males subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-10-01,531.0,0.007467724242679942
m15 [laboratory testing],15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.2.c,Number of HIV reactive females (non-ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.c,Number of HIV reactive PW(ANC) subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.g,Number of HIV reactive DIL women subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV",2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.c,Number of HIV reactive H/TG people subjected to HIV test at Confirmatory Centre (Stand Alone-ICTC) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-10-01,10.0,0.00014063510814839815
m15 [laboratory testing],15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.1.c,"Out of the above, number of males treated for Syphilis ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-10-01,317.0,0.004458132928304222
m15 [laboratory testing],15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",2024-10-01,0.0,0.0
m15 [laboratory testing],15.5.1,Widal tests- Number Tested,2024-10-01,97.0,0.0013641605490394622
m15 [laboratory testing],15.5.2,Widal tests- Number Positive,2024-10-01,15.0,0.00021095266222259724
m15 [laboratory testing],15.6.1.a.i,X-ray(Inhouse),2024-10-01,3116.0,0.043821899699040864
m15 [laboratory testing],15.6.1.a.ii,X-ray(Outsource),2024-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.b.i,Ultrasonography (USG) (Inhouse),2024-10-01,1480.0,0.02081399600596293
m15 [laboratory testing],15.6.1.b.ii,Ultrasonography (USG)(Outsource),2024-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.c.i,CT scan (Inhouse),2024-10-01,543.0,0.00763648637245802
m15 [laboratory testing],15.6.1.c.ii,CT scan (Outsource),2024-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.d.i,MRI (Inhouse),2024-10-01,243.0,0.0034174331280060755
m15 [laboratory testing],15.6.1.d.ii,MRI (Outsource),2024-10-01,0.0,0.0
m15 [laboratory testing],15.6.1.e.i,ECG (Inhouse),2024-10-01,811.0,0.011405507270835091
m15 [laboratory testing],15.6.1.e.ii,ECG (Outsource),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-04-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-04-01,4.0,5.6254043259359264e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-04-01,15.0,0.00021095266222259724
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-04-01,15.0,0.00021095266222259724
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-05-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-05-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-05-01,22.0,0.00030939723792647593
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-05-01,22.0,0.00030939723792647593
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-06-01,4.0,5.6254043259359264e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-06-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-06-01,21.0,0.00029533372711163615
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-06-01,21.0,0.00029533372711163615
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-07-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-07-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-07-01,28.0,0.00039377830281551486
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-07-01,28.0,0.00039377830281551486
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-08-01,10.0,0.00014063510814839815
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-08-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-08-01,28.0,0.00039377830281551486
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-08-01,28.0,0.00039377830281551486
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-09-01,4.0,5.6254043259359264e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-09-01,13.0,0.00018282564059291762
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-09-01,13.0,0.00018282564059291762
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-10-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-10-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-10-01,13.0,0.00018282564059291762
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-11-01,11.0,0.00015469861896323797
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-11-01,2.0,2.8127021629679632e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-11-01,31.0,0.00043596883526003427
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-11-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2023-12-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2023-12-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2023-12-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2023-12-01,2.0,2.8127021629679632e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2023-12-01,13.0,0.00018282564059291762
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2023-12-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-01-01,10.0,0.00014063510814839815
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-01-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-01-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-01-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-02-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-02-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-02-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-02-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-02-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-02-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-03-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-03-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-03-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-03-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-03-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-04-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-04-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-04-01,5.0,7.031755407419908e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-04-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-04-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-05-01,5.0,7.031755407419908e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-05-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-05-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-06-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-06-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-06-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-06-01,7.0,9.844457570387872e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-06-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-06-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-07-01,11.0,0.00015469861896323797
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-07-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-07-01,2.0,2.8127021629679632e-05
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-07-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-08-01,6.0,8.43810648890389e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-08-01,5.0,7.031755407419908e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-08-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-08-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-09-01,2.0,2.8127021629679632e-05
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-09-01,1.0,1.4063510814839816e-05
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-09-01,7.0,9.844457570387872e-05
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-09-01,3.0,4.219053244451945e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-09-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.a,Infant Deaths (>28 days to 12 months) at Facility/Facility to facility in transit,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.1.4.b,Infant Deaths (>28 days to 12 months) At Community (at home or home to facility transit),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.1,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.2,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.3,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.2.4,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.1,Number of Infant Deaths (>28 days - 12 months) due to Pneumonia,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.2,Number of Infant Deaths (>28 days - 12 months) due to Diarrhoea,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.3,Number of Infant Deaths (>28 days - 12 months) due to Fever related,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.4,Number of Infant Deaths (>28 days - 12 months) due to Measles,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.3.5,Number of Infant Deaths (>28 days - 12 months) due to Others,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.1,Number of Child Deaths (1 -5 years) due to Pneumonia,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.2,Number of Child Deaths (1 -5 years) due to Diarrhoea,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.3,Number of Child Deaths (1 -5 years) due to Fever related,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.4,Number of Child Deaths (1 -5 years) due to Measles,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.4.5,Number of Child Deaths (1 -5 years) due to Others,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.1,Number of Maternal Deaths due to APH (Antepartum Haemmorhage),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.2,Number of Maternal Deaths due to PPH (Post-Partum Haemmorhage),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.3,"Number of Maternal Deaths due to Pregnancy related infection and sepsis, Fever",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.4,Number of Maternal Deaths due to Abortive complication,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.5,Number of Maternal Deaths due to Obstructed/prolonged labour,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.6,"Number of Maternal Deaths due to Severe hypertension/fits & Hypertensive disorder in pregnancy, birth and puerperium",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.7,Number of Maternal Deaths due to Other/Unknown Causes,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8,"Age wise total Maternal Deaths, occurred at Facility",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.8.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.9,"Total Maternal Deaths, occurred at Home to be reported at Block level",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.10,Maternal Death in transit to be reported at Block level,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.a,"Out of total number of maternal deaths, deaths with age<15 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.b,"Out of total number of maternal deaths, deaths with age 15-19 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.c,"Out of total number maternal deaths, deaths with age more than >19-49 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.5.11.d,"Out of total number maternal deaths, deaths with age more than >49 years",2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.6,Total Facility Based Maternal Death Reviews (FBMDR) done,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.1,Number of deaths due to Diarrhoeal diseases,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.2,Number of deaths due to Tuberculosis,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.3,Number of deaths due to Respiratory diseases including infections (other than TB),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.4,Number of deaths due to Other Fever Related,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.5,Number of deaths due to Heart disease/Hypertension related,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.6,Number of deaths due to Cancer,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.7,Number of deaths due to Neurological disease including strokes,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.8,Number of deaths due to Accidents/Burn cases ,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.9,Number of deaths due to Self Harm,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.10,Number of deaths due to Animal bites and stings,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.7.11,Number of deaths due to Known Acute Disease,2024-10-01,9.0,0.00012657159733355834
m16 [details of deaths reported with probable causes:],16.7.12,Number of deaths due to Known Chronic Disease,2024-10-01,4.0,5.6254043259359264e-05
m16 [details of deaths reported with probable causes:],16.7.13,Number of deaths due to Other Causes ,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.1,Number of Deaths due to Malaria- Plasmodium Vivax,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.2,Number of Deaths due to Malaria- Plasmodium Falciparum,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.3,Number of Deaths due to Kala Azar,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.4,Number of Deaths due to Dengue,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.5,Number of Deaths due to Acute Encephelitis Syndrome (AES),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.8.6,Number of Deaths due to Japanese Encephalitis (JE),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9,Total Deaths (above 5 years of age),2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.1,Above 5 years to below 10 years,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.2,Above 10 years to below 19 years,2024-10-01,0.0,0.0
m16 [details of deaths reported with probable causes:],16.9.3,Adult above >19 years,2024-10-01,0.0,0.0
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-04-01,0.0,0.0
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-04-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-04-01,0.0,0.0
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-04-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-04-01,0.0,0.0
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-04-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-04-01,159.0,0.002236098219559531
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-04-01,159.0,0.002236098219559531
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-04-01,15.0,0.00021095266222259724
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-05-01,0.0,0.0
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-05-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-05-01,0.0,0.0
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-05-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-05-01,0.0,0.0
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-05-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-05-01,140.0,0.0019688915140775743
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-05-01,140.0,0.0019688915140775743
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-05-01,14.0,0.00019688915140775743
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-06-01,0.0,0.0
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-06-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-06-01,0.0,0.0
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-06-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-06-01,0.0,0.0
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-06-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-06-01,173.0,0.0024329873709672883
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-06-01,173.0,0.0024329873709672883
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-06-01,12.0,0.0001687621297780778
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-07-01,13.0,0.00018282564059291762
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-07-01,13.0,0.00018282564059291762
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-07-01,47.0,0.0006609850082974713
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-07-01,45.0,0.0006328579866677918
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-07-01,73.0,0.0010266362894833065
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-07-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-07-01,0.0,0.0
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-07-01,0.0,0.0
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-07-01,0.0,0.0
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-08-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-08-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-08-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-08-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-08-01,83.0,0.0011672713976317048
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-08-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-08-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-08-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-08-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-09-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-09-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-09-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-09-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-09-01,88.0,0.0012375889517059037
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-09-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-09-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-09-01,1.0,1.4063510814839816e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-09-01,1.0,1.4063510814839816e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-10-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-10-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-10-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-10-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-10-01,106.0,0.0014907321463730205
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-10-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-10-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-10-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-10-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-11-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-11-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-11-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-11-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-11-01,164.0,0.00230641577363373
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-11-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-11-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-11-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-11-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2023-12-01,0.0,0.0
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2023-12-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2023-12-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2023-12-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2023-12-01,240.0,0.003375242595561556
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2023-12-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2023-12-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2023-12-01,2.0,2.8127021629679632e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2023-12-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-01-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-01-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-01-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-01-01,2.0,2.8127021629679632e-05
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-01-01,1382.0,0.019435771946108626
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-01-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-01-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-01-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-01-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-02-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-02-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-02-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-02-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-02-01,185.0,0.002601749500745366
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-02-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-02-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-02-01,2.0,2.8127021629679632e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-02-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-03-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-03-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-03-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-03-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-03-01,198.0,0.0027845751413382836
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-03-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-03-01,7.0,9.844457570387872e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-03-01,7.0,9.844457570387872e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-03-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-04-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-04-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-04-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-04-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-04-01,208.0,0.002925210249486682
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-04-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-04-01,7.0,9.844457570387872e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-04-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-04-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-05-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-05-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-05-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-05-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-05-01,249.0,0.003501814192895114
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-05-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-05-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-05-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-05-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-06-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-06-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-06-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-06-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-06-01,255.0,0.003586195257784153
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-06-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-06-01,7.0,9.844457570387872e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-06-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-06-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-07-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-07-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-07-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-07-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-07-01,250.0,0.003515877703709954
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-07-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-07-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-07-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-07-01,2.0,2.8127021629679632e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-08-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-08-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-08-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-08-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-08-01,232.0,0.003262734509042837
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-08-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-08-01,6.0,8.43810648890389e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-08-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-08-01,2.0,2.8127021629679632e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-09-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-09-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-09-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-09-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-09-01,264.0,0.0037127668551177116
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-09-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-09-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-09-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-09-01,3.0,4.219053244451945e-05
m17 [qa & bemmp],17.1.1,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,2024-10-01,16.0,0.00022501617303743706
m17 [qa & bemmp],17.1.2,No. of registered Haematology tests reported EQAS Compliant,2024-10-01,0.0,0.0
m17 [qa & bemmp],17.1.3,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,2024-10-01,69.0,0.0009703822462239473
m17 [qa & bemmp],17.1.4,No. of registered Bio chemistry tests report EQAS Compliant,2024-10-01,0.0,0.0
m17 [qa & bemmp],17.1.5,"Total Quantity of Bio medical waste generated in Kg for the month (All Yellow, Red, white & Blue)",2024-10-01,399.0,0.005611340815121086
m17 [qa & bemmp],17.1.6,Total Quantity of General waste generated in Kg for the month,2024-10-01,0.0,0.0
m17 [qa & bemmp],17.2.1,Total number of breakdown calls reported for the month,2024-10-01,7.0,9.844457570387872e-05
m17 [qa & bemmp],17.2.2,Total number of breakdown attended for the month,2024-10-01,5.0,7.031755407419908e-05
m17 [qa & bemmp],17.2.3,Number of visit made by the service engineer/ BME for the month,2024-10-01,7.0,9.844457570387872e-05
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-04-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-04-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-04-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-04-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-04-01,100.0,0.0014063510814839816
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-04-01,51.0,0.0007172390515568306
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-04-01,2.0,2.8127021629679632e-05
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-04-01,100.0,0.0014063510814839816
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-04-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-04-01,0.0,0.0
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-04-01,100.0,0.0014063510814839816
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-04-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-04-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-04-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-04-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-05-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-05-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-05-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-05-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-05-01,110.0,0.0015469861896323797
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-05-01,54.0,0.00075942958400135
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-05-01,34.0,0.00047815936770455374
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-05-01,110.0,0.0015469861896323797
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-05-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-05-01,10.0,0.00014063510814839815
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-05-01,100.0,0.0014063510814839816
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-05-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-05-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-05-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-05-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-06-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-06-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-06-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-06-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-06-01,117.0,0.0016454307653362584
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-06-01,61.0,0.0008578741597052288
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-06-01,32.0,0.0004500323460748741
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-06-01,117.0,0.0016454307653362584
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-06-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-06-01,14.0,0.00019688915140775743
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-06-01,103.0,0.001448541613928501
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-06-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-06-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-06-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-06-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-07-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-07-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-07-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-07-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-07-01,107.0,0.0015047956571878603
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-07-01,50.0,0.0007031755407419908
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-07-01,25.0,0.0003515877703709954
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-07-01,107.0,0.0015047956571878603
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-07-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-07-01,10.0,0.00014063510814839815
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-07-01,97.0,0.0013641605490394622
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-07-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-07-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-07-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-07-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-08-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-08-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-08-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-08-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-08-01,125.0,0.001757938851854977
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-08-01,67.0,0.0009422552245942677
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-08-01,23.0,0.00032346074874131577
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-08-01,125.0,0.001757938851854977
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-08-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-08-01,0.0,0.0
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-08-01,125.0,0.001757938851854977
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-08-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-08-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-08-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-08-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-09-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-09-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-09-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-09-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-09-01,106.0,0.0014907321463730205
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-09-01,54.0,0.00075942958400135
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-09-01,15.0,0.00021095266222259724
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-09-01,106.0,0.0014907321463730205
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-09-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-09-01,4.0,5.6254043259359264e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-09-01,102.0,0.0014344781031136612
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-09-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-09-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-09-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-09-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-10-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-10-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-10-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-10-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-10-01,138.0,0.0019407644924478945
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-10-01,74.0,0.0010406998002981463
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-10-01,14.0,0.00019688915140775743
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-10-01,138.0,0.0019407644924478945
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-10-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-10-01,4.0,5.6254043259359264e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-10-01,134.0,0.0018845104491885354
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-10-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-10-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-10-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-10-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-11-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-11-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-11-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-11-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-11-01,117.0,0.0016454307653362584
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-11-01,56.0,0.0007875566056310297
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-11-01,23.0,0.00032346074874131577
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-11-01,117.0,0.0016454307653362584
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-11-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-11-01,4.0,5.6254043259359264e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-11-01,113.0,0.0015891767220768992
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-11-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-11-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-11-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-11-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2023-12-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2023-12-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2023-12-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2023-12-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2023-12-01,137.0,0.0019267009816330547
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2023-12-01,62.0,0.0008719376705200685
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2023-12-01,27.0,0.000379714792000675
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2023-12-01,137.0,0.0019267009816330547
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2023-12-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2023-12-01,4.0,5.6254043259359264e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2023-12-01,133.0,0.0018704469383736956
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2023-12-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2023-12-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2023-12-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2023-12-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-01-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-01-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-01-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-01-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-01-01,113.0,0.0015891767220768992
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-01-01,60.0,0.000843810648890389
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-01-01,30.0,0.0004219053244451945
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-01-01,113.0,0.0015891767220768992
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-01-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-01-01,19.0,0.0002672067054819565
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-01-01,94.0,0.0013219700165949427
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-01-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-01-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-01-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-01-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-02-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-02-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-02-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-02-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-02-01,128.0,0.0018001293842994964
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-02-01,76.0,0.001068826821927826
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-02-01,42.0,0.0005906674542232723
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-02-01,128.0,0.0018001293842994964
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-02-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-02-01,0.0,0.0
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-02-01,14.0,0.00019688915140775743
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-02-01,114.0,0.001603240232891739
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-02-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-02-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-02-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-03-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-03-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-03-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-03-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-03-01,140.0,0.0019688915140775743
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-03-01,75.0,0.0010547633111129863
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-03-01,33.0,0.00046409585688971395
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-03-01,140.0,0.0019688915140775743
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-03-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-03-01,6.0,8.43810648890389e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-03-01,134.0,0.0018845104491885354
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-03-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-03-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-03-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-03-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-04-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-04-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-04-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-04-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-04-01,161.0,0.0022642252411892104
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-04-01,86.0,0.0012094619300762242
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-04-01,31.0,0.00043596883526003427
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-04-01,161.0,0.0022642252411892104
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-04-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-04-01,5.0,7.031755407419908e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-04-01,156.0,0.0021939076871150113
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-04-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-04-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-04-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-04-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-05-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-05-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-05-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-05-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-05-01,181.0,0.0025454954574860066
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-05-01,96.0,0.0013500970382246224
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-05-01,60.0,0.000843810648890389
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-05-01,181.0,0.0025454954574860066
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-05-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-05-01,0.0,0.0
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-05-01,181.0,0.0025454954574860066
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-05-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-05-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-05-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-05-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-06-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-06-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-06-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-06-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-06-01,144.0,0.0020251455573369334
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-06-01,71.0,0.000998509267853627
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-06-01,29.0,0.00040784181363035465
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-06-01,144.0,0.0020251455573369334
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-06-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-06-01,2.0,2.8127021629679632e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-06-01,142.0,0.001997018535707254
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-06-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-06-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-06-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-06-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-07-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-07-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-07-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-07-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-07-01,122.0,0.0017157483194104575
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-07-01,64.0,0.0009000646921497482
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-07-01,23.0,0.00032346074874131577
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-07-01,122.0,0.0017157483194104575
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-07-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-07-01,2.0,2.8127021629679632e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-07-01,120.0,0.001687621297780778
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-07-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-07-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-07-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-07-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-08-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-08-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-08-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-08-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-08-01,174.0,0.002447050881782128
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-08-01,105.0,0.0014766686355581807
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-08-01,46.0,0.0006469214974826315
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-08-01,174.0,0.002447050881782128
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-08-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-08-01,4.0,5.6254043259359264e-05
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-08-01,170.0,0.0023907968385227687
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-08-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-08-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-08-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-08-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-09-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-09-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-09-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-09-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-09-01,160.0,0.0022501617303743704
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-09-01,79.0,0.0011110173543723454
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-09-01,41.0,0.0005766039434084325
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-09-01,160.0,0.0022501617303743704
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-09-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-09-01,16.0,0.00022501617303743706
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-09-01,144.0,0.0020251455573369334
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-09-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-09-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-09-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-09-01,0.0,0.0
m2 [deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2024-10-01,0.0,0.0
m2 [deliveries],2.1.1.b,Number of Home Deliveries attended by Non SBA (Trained Birth Attendant(TBA) /Relatives/etc.),2024-10-01,0.0,0.0
m2 [deliveries],2.1.2,Number of PW given Tablet Misoprostol during home delivery,2024-10-01,0.0,0.0
m2 [deliveries],2.1.3,Number of newborns received 7 Home Based Newborn Care (HBNC) visits in case of Home delivery,2024-10-01,0.0,0.0
m2 [deliveries],2.2,Number of Institutional Deliveries conducted (Including C-Sections),2024-10-01,191.0,0.002686130565634405
m2 [deliveries],2.2.1,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery",2024-10-01,86.0,0.0012094619300762242
m2 [deliveries],2.2.2,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM)",2024-10-01,43.0,0.0006047309650381121
m2 [deliveries],2.3,Age wise total number of delivery (Home +Institutional) reported (2.3.1+2.3.2+2.3.3+2.3.4),2024-10-01,191.0,0.002686130565634405
m2 [deliveries],2.3.1,"Out of total number of delivery, PW with age <15 years",2024-10-01,0.0,0.0
m2 [deliveries],2.3.2,"Out of total number of delivery, PW with age 15-19 years",2024-10-01,19.0,0.0002672067054819565
m2 [deliveries],2.3.3,"Out of total number of delivery, PW with age >19-49 years",2024-10-01,172.0,0.0024189238601524483
m2 [deliveries],2.3.4,"Out of total number of delivery, PW with age > 49 years",2024-10-01,0.0,0.0
m2 [deliveries],2.4,Number of newborns received 6 HBNC visits after Institutional Delivery,2024-10-01,0.0,0.0
m2 [deliveries],2.5,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme,2024-10-01,0.0,0.0
m2 [deliveries],2.6,Total number of Children received all scheduled 5 Home visits under HBYC ,2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-11-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2023-12-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-01-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-02-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-03-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-04-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-05-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-06-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-07-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-08-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-09-01,0.0,0.0
m20 [death reviews (mdr) done],20.1,Total Maternal Deaths Reviewed (MDR) by CMO,2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.2,Total Maternal Deaths Reviewed (MDR) by DM,2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.3,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.4,Total number of Child Deaths Reviewed by CMHO Level,2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.5,Total number of Child Deaths Reviewed by DM Level,2024-10-01,0.0,0.0
m20 [death reviews (mdr) done],20.6,Number of Child Deaths reviewed through Community based Child Death Review (CBCDR),2024-10-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-04-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-05-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-06-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-07-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-08-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-09-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-10-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-11-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2023-12-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-01-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-02-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-03-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-04-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-05-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-06-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-07-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-08-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-09-01,0.0,0.0
m21 [national ambulance services ],21.1,Average response time (call to scene) for all BLS Ambulances in the district during the month,2024-10-01,0.0,0.0
m21 [national ambulance services ],21.2,Average response time (call to scene) for all ALS Ambulances in the district during the month,2024-10-01,0.0,0.0
m21 [national ambulance services ],21.3,Average number of trips per day by all ALS Ambulances in the district during the month ,2024-10-01,0.0,0.0
m21 [national ambulance services ],21.4,Average number of trips per day by all BLS Ambulances in the district during the month,2024-10-01,0.0,0.0
m21 [national ambulance services ],21.5,Average kilometres travelled by all ALS Ambulances in the district during the month,2024-10-01,0.0,0.0
m21 [national ambulance services ],21.6,Average kilometres travelled by all BLS Ambulances in the district during the month,2024-10-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-04-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-05-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-06-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-07-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-08-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-09-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-10-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-11-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2023-12-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-01-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-02-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-03-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-04-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-05-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-06-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-07-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-08-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-09-01,0.0,0.0
m22 [nlep],22.1,No. of new leprosy cases found during monthly survey,2024-10-01,0.0,0.0
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-04-01,49.0,0.000689112029927151
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-04-01,8.0,0.00011250808651871853
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-04-01,49.0,0.000689112029927151
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-05-01,56.0,0.0007875566056310297
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-05-01,7.0,9.844457570387872e-05
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-05-01,56.0,0.0007875566056310297
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-06-01,56.0,0.0007875566056310297
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-06-01,6.0,8.43810648890389e-05
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-06-01,56.0,0.0007875566056310297
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-07-01,57.0,0.0008016201164458695
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-07-01,5.0,7.031755407419908e-05
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-07-01,57.0,0.0008016201164458695
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-08-01,58.0,0.0008156836272607093
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-08-01,9.0,0.00012657159733355834
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-08-01,58.0,0.0008156836272607093
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-09-01,52.0,0.0007313025623716705
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-09-01,8.0,0.00011250808651871853
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-09-01,52.0,0.0007313025623716705
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-10-01,64.0,0.0009000646921497482
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-10-01,11.0,0.00015469861896323797
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-10-01,64.0,0.0009000646921497482
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-11-01,61.0,0.0008578741597052288
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-11-01,15.0,0.00021095266222259724
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-11-01,61.0,0.0008578741597052288
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2023-12-01,75.0,0.0010547633111129863
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2023-12-01,25.0,0.0003515877703709954
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2023-12-01,75.0,0.0010547633111129863
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-01-01,53.0,0.0007453660731865103
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-01-01,10.0,0.00014063510814839815
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-01-01,53.0,0.0007453660731865103
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-02-01,52.0,0.0007313025623716705
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-02-01,8.0,0.00011250808651871853
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-02-01,52.0,0.0007313025623716705
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-03-01,65.0,0.000914128202964588
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-03-01,16.0,0.00022501617303743706
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-03-01,65.0,0.000914128202964588
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-04-01,75.0,0.0010547633111129863
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-04-01,32.0,0.0004500323460748741
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-04-01,75.0,0.0010547633111129863
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-05-01,85.0,0.0011953984192613844
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-05-01,25.0,0.0003515877703709954
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-05-01,85.0,0.0011953984192613844
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-06-01,73.0,0.0010266362894833065
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-06-01,21.0,0.00029533372711163615
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-06-01,73.0,0.0010266362894833065
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-07-01,58.0,0.0008156836272607093
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-07-01,21.0,0.00029533372711163615
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-07-01,58.0,0.0008156836272607093
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-08-01,69.0,0.0009703822462239473
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-08-01,24.0,0.0003375242595561556
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-08-01,69.0,0.0009703822462239473
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-09-01,81.0,0.001139144376002025
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-09-01,30.0,0.0004219053244451945
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-09-01,81.0,0.001139144376002025
m3 [number of caesarean (c-section) deliveries],3.1,Total number of C -Section deliveries performed,2024-10-01,102.0,0.0014344781031136612
m3 [number of caesarean (c-section) deliveries],3.1.1,"Out of total C-sections, number performed at night (8 PM- 8 AM)",2024-10-01,36.0,0.0005062863893342334
m3 [number of caesarean (c-section) deliveries],3.1.2,"Out of total C-section, number of women stayed for 72 hours or more after delivery",2024-10-01,99.0,0.0013922875706691418
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-04-01,46.0,0.0006469214974826315
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-04-01,53.0,0.0007453660731865103
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-04-01,7.0,9.844457570387872e-05
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-04-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-04-01,99.0,0.0013922875706691418
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-04-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-04-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-04-01,99.0,0.0013922875706691418
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-04-01,99.0,0.0013922875706691418
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-04-01,99.0,0.0013922875706691418
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-05-01,60.0,0.000843810648890389
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-05-01,49.0,0.000689112029927151
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-05-01,9.0,0.00012657159733355834
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-05-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-05-01,109.0,0.0015329226788175399
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-05-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-05-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-05-01,109.0,0.0015329226788175399
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-05-01,109.0,0.0015329226788175399
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-05-01,109.0,0.0015329226788175399
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-06-01,58.0,0.0008156836272607093
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-06-01,54.0,0.00075942958400135
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-06-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-06-01,5.0,7.031755407419908e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-06-01,112.0,0.0015751132112620594
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-06-01,8.0,0.00011250808651871853
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-06-01,112.0,0.0015751132112620594
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-06-01,112.0,0.0015751132112620594
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-06-01,112.0,0.0015751132112620594
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-07-01,54.0,0.00075942958400135
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-07-01,52.0,0.0007313025623716705
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-07-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-07-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-07-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-07-01,26.0,0.00036565128118583524
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-07-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-07-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-07-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-07-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-07-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-07-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-07-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-08-01,67.0,0.0009422552245942677
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-08-01,58.0,0.0008156836272607093
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-08-01,9.0,0.00012657159733355834
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-08-01,125.0,0.001757938851854977
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-08-01,25.0,0.0003515877703709954
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-08-01,11.0,0.00015469861896323797
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-08-01,125.0,0.001757938851854977
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-08-01,125.0,0.001757938851854977
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-08-01,125.0,0.001757938851854977
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-08-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-08-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-09-01,53.0,0.0007453660731865103
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-09-01,53.0,0.0007453660731865103
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-09-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-09-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-09-01,7.0,9.844457570387872e-05
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-09-01,5.0,7.031755407419908e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-09-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-09-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-09-01,106.0,0.0014907321463730205
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-10-01,67.0,0.0009422552245942677
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-10-01,69.0,0.0009703822462239473
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-10-01,20.0,0.0002812702162967963
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-10-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-10-01,136.0,0.001912637470818215
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-10-01,14.0,0.00019688915140775743
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-10-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-10-01,136.0,0.001912637470818215
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-10-01,136.0,0.001912637470818215
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-10-01,136.0,0.001912637470818215
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-11-01,52.0,0.0007313025623716705
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-11-01,64.0,0.0009000646921497482
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-11-01,9.0,0.00012657159733355834
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-11-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-11-01,116.0,0.0016313672545214186
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-11-01,15.0,0.00021095266222259724
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-11-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-11-01,116.0,0.0016313672545214186
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-11-01,116.0,0.0016313672545214186
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-11-01,116.0,0.0016313672545214186
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-11-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2023-12-01,77.0,0.0010828903327426659
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2023-12-01,57.0,0.0008016201164458695
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2023-12-01,13.0,0.00018282564059291762
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2023-12-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2023-12-01,134.0,0.0018845104491885354
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2023-12-01,28.0,0.00039377830281551486
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2023-12-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2023-12-01,134.0,0.0018845104491885354
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2023-12-01,134.0,0.0018845104491885354
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2023-12-01,134.0,0.0018845104491885354
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2023-12-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-01-01,57.0,0.0008016201164458695
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-01-01,56.0,0.0007875566056310297
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-01-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-01-01,113.0,0.0015891767220768992
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-01-01,6.0,8.43810648890389e-05
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-01-01,113.0,0.0015891767220768992
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-01-01,113.0,0.0015891767220768992
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-01-01,113.0,0.0015891767220768992
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-01-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-01-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-02-01,69.0,0.0009703822462239473
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-02-01,57.0,0.0008016201164458695
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-02-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-02-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-02-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-02-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-02-01,126.0,0.0017720023626698169
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-02-01,19.0,0.0002672067054819565
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-02-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-02-01,126.0,0.0017720023626698169
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-02-01,126.0,0.0017720023626698169
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-02-01,126.0,0.0017720023626698169
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-02-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-02-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-02-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-03-01,72.0,0.0010125727786684667
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-03-01,66.0,0.0009281917137794279
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-03-01,18.0,0.0002531431946671167
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-03-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-03-01,138.0,0.0019407644924478945
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-03-01,22.0,0.00030939723792647593
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-03-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-03-01,138.0,0.0019407644924478945
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-03-01,138.0,0.0019407644924478945
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-03-01,138.0,0.0019407644924478945
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-03-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-04-01,94.0,0.0013219700165949427
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-04-01,71.0,0.000998509267853627
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-04-01,11.0,0.00015469861896323797
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-04-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-04-01,165.0,0.0023204792844485696
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-04-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-04-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-04-01,165.0,0.0023204792844485696
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-04-01,165.0,0.0023204792844485696
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-04-01,165.0,0.0023204792844485696
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-04-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-05-01,87.0,0.001223525440891064
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-05-01,94.0,0.0013219700165949427
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-05-01,12.0,0.0001687621297780778
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-05-01,10.0,0.00014063510814839815
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-05-01,181.0,0.0025454954574860066
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-05-01,35.0,0.0004922228785193936
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-05-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-05-01,181.0,0.0025454954574860066
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-05-01,181.0,0.0025454954574860066
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-05-01,181.0,0.0025454954574860066
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-05-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-06-01,74.0,0.0010406998002981463
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-06-01,66.0,0.0009281917137794279
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-06-01,22.0,0.00030939723792647593
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-06-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-06-01,3.0,4.219053244451945e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-06-01,7.0,9.844457570387872e-05
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-06-01,140.0,0.0019688915140775743
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-06-01,20.0,0.0002812702162967963
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-06-01,5.0,7.031755407419908e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-06-01,140.0,0.0019688915140775743
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-06-01,140.0,0.0019688915140775743
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-06-01,140.0,0.0019688915140775743
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-06-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-07-01,56.0,0.0007875566056310297
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-07-01,66.0,0.0009281917137794279
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-07-01,16.0,0.00022501617303743706
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-07-01,1.0,1.4063510814839816e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-07-01,9.0,0.00012657159733355834
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-07-01,122.0,0.0017157483194104575
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-07-01,21.0,0.00029533372711163615
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-07-01,9.0,0.00012657159733355834
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-07-01,122.0,0.0017157483194104575
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-07-01,122.0,0.0017157483194104575
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-07-01,122.0,0.0017157483194104575
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-07-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-08-01,82.0,0.001153207886816865
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-08-01,90.0,0.0012657159733355835
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-08-01,22.0,0.00030939723792647593
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-08-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-08-01,172.0,0.0024189238601524483
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-08-01,32.0,0.0004500323460748741
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-08-01,5.0,7.031755407419908e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-08-01,172.0,0.0024189238601524483
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-08-01,172.0,0.0024189238601524483
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-08-01,172.0,0.0024189238601524483
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-08-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-09-01,84.0,0.0011813349084465446
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-09-01,74.0,0.0010406998002981463
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-09-01,17.0,0.00023907968385227687
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-09-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-09-01,158.0,0.002222034708744691
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-09-01,38.0,0.000534413410963913
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-09-01,4.0,5.6254043259359264e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-09-01,158.0,0.002222034708744691
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-09-01,158.0,0.002222034708744691
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-09-01,158.0,0.002222034708744691
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-09-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-09-01,5.0,7.031755407419908e-05
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-09-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male,2024-10-01,108.0,0.0015188591680027
m4 [pregnancy outcome & details of new-born],4.1.1.b,Live Birth - Female,2024-10-01,83.0,0.0011672713976317048
m4 [pregnancy outcome & details of new-born],4.1.2,Number of Pre-term newborns ( < 37 weeks of pregnancy),2024-10-01,19.0,0.0002672067054819565
m4 [pregnancy outcome & details of new-born],4.1.3.a,Intrapartum (Fresh) Still Birth,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.1.3.b,Antepartum (Macerated) Still Birth,2024-10-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.2,Abortion (spontaneous),2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.4.1,Number of Newborns weighed at birth,2024-10-01,191.0,0.002686130565634405
m4 [pregnancy outcome & details of new-born],4.4.2,Number of Newborns having weight less than 2500 gms,2024-10-01,46.0,0.0006469214974826315
m4 [pregnancy outcome & details of new-born],4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms",2024-10-01,2.0,2.8127021629679632e-05
m4 [pregnancy outcome & details of new-born],4.4.3,Number of Newborns breast fed within 1 hour of birth,2024-10-01,126.0,0.0017720023626698169
m4 [pregnancy outcome & details of new-born],4.4.4,No. of Newborns discharged from the facility were exclusively breastfed till discharge,2024-10-01,191.0,0.002686130565634405
m4 [pregnancy outcome & details of new-born],4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.1,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK)",2024-10-01,191.0,0.002686130565634405
m4 [pregnancy outcome & details of new-born],4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down's Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip)",2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center ,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools ,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.3,Number of SNCU discharged babies screened in DEIC,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.a.1,Number of children identified with Disease by RBSK Mobile Health teams,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.b.1,Number of children identified with Deficiency by RBSK Mobile Health teams,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.c.1,Number of children identified with Developmental delay by RBSK Mobile Health teams,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.4.d.1,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.5,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.6,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical,2024-10-01,0.0,0.0
m4 [pregnancy outcome & details of new-born],4.5.7,Number of children till age 18 years managed at DEIC (District Early Intervention Centre),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-04-01,50.0,0.0007031755407419908
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-07-01,6.0,8.43810648890389e-05
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-08-01,12.0,0.0001687621297780778
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-09-01,2.0,2.8127021629679632e-05
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-10-01,2.0,2.8127021629679632e-05
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-10-01,2.0,2.8127021629679632e-05
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-11-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-11-01,2.0,2.8127021629679632e-05
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2023-12-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2023-12-01,4.0,5.6254043259359264e-05
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-01-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-01-01,12.0,0.0001687621297780778
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-02-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-02-01,12.0,0.0001687621297780778
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-03-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-04-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-05-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-06-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-07-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-08-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-09-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.1,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month",2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.2,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.e,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.1.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl)",2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia ((Hb <8 g/dl),2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment,2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment",2024-10-01,0.0,0.0
m5 [anaemia mukt bharat],5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment,2024-10-01,0.0,0.0
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-04-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-04-01,99.0,0.0013922875706691418
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-04-01,99.0,0.0013922875706691418
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-04-01,99.0,0.0013922875706691418
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-05-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-05-01,109.0,0.0015329226788175399
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-05-01,109.0,0.0015329226788175399
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-05-01,109.0,0.0015329226788175399
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-06-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-06-01,110.0,0.0015469861896323797
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-06-01,112.0,0.0015751132112620594
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-06-01,112.0,0.0015751132112620594
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-07-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-07-01,106.0,0.0014907321463730205
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-07-01,106.0,0.0014907321463730205
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-07-01,106.0,0.0014907321463730205
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-08-01,125.0,0.001757938851854977
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-08-01,125.0,0.001757938851854977
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-08-01,125.0,0.001757938851854977
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-08-01,125.0,0.001757938851854977
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-09-01,94.0,0.0013219700165949427
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-09-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-09-01,0.0,0.0
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-09-01,0.0,0.0
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-10-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-10-01,187.0,0.0026298765223750457
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-10-01,187.0,0.0026298765223750457
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-10-01,187.0,0.0026298765223750457
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-11-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-11-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-11-01,117.0,0.0016454307653362584
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-11-01,117.0,0.0016454307653362584
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2023-12-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2023-12-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2023-12-01,208.0,0.002925210249486682
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2023-12-01,208.0,0.002925210249486682
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-01-01,2.0,2.8127021629679632e-05
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-01-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-01-01,0.0,0.0
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-01-01,0.0,0.0
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-02-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-02-01,201.0,0.002826765673782803
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-02-01,201.0,0.002826765673782803
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-02-01,201.0,0.002826765673782803
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-03-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-03-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-03-01,0.0,0.0
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-03-01,0.0,0.0
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-04-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-04-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-04-01,161.0,0.0022642252411892104
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-04-01,161.0,0.0022642252411892104
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-05-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-05-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-05-01,181.0,0.0025454954574860066
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-05-01,181.0,0.0025454954574860066
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-06-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-06-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-06-01,140.0,0.0019688915140775743
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-06-01,140.0,0.0019688915140775743
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-07-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-07-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-07-01,122.0,0.0017157483194104575
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-07-01,122.0,0.0017157483194104575
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-08-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-08-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-08-01,172.0,0.0024189238601524483
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-08-01,172.0,0.0024189238601524483
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-09-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-09-01,158.0,0.002222034708744691
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-09-01,158.0,0.002222034708744691
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-09-01,158.0,0.002222034708744691
m6 [post natal care (pnc)],6.1,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours",2024-10-01,0.0,0.0
m6 [post natal care (pnc)],6.2,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery,2024-10-01,0.0,0.0
m6 [post natal care (pnc)],6.3,Number of mothers provided full course of 180 IFA tablets after delivery,2024-10-01,191.0,0.002686130565634405
m6 [post natal care (pnc)],6.4,Number of mothers provided full course 360 Calcium tablets after delivery,2024-10-01,191.0,0.002686130565634405
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-11-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2023-12-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-01-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-02-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-03-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-04-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-05-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-06-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-07-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-08-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-09-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1,Number of males assessed for STI/RTI,2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI",2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.1.b,"Out of the above, number of males treated for STI/RTI",2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2,Number of females (all females) assessed for STI/RTI,2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI",2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI",2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3,Number of H/TG assessed for STI/RTI,2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI",2024-10-01,0.0,0.0
m7 [reproductive tract infections/sexually transmitted infections (rti/sti) cases],7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI",2024-10-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-04-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-04-01,12.0,0.0001687621297780778
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-04-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-04-01,10.0,0.00014063510814839815
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-04-01,4.0,5.6254043259359264e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-04-01,10.0,0.00014063510814839815
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-04-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-04-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-04-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-04-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-04-01,11.0,0.00015469861896323797
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-04-01,12.0,0.0001687621297780778
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-04-01,6.0,8.43810648890389e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-04-01,2.0,2.8127021629679632e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-04-01,30.0,0.0004219053244451945
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-04-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-04-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-04-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-04-01,0.0,0.0
m8 [family planning],8.17.1,Complications following male sterilization,2023-04-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-04-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-04-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-04-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-04-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-04-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-04-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-04-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-05-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-05-01,19.0,0.0002672067054819565
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-05-01,4.0,5.6254043259359264e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-05-01,10.0,0.00014063510814839815
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-05-01,4.0,5.6254043259359264e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-05-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-05-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-05-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-05-01,7.0,9.844457570387872e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-05-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-05-01,9.0,0.00012657159733355834
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-05-01,12.0,0.0001687621297780778
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-05-01,6.0,8.43810648890389e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-05-01,2.0,2.8127021629679632e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-05-01,22.0,0.00030939723792647593
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-05-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-05-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-05-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-05-01,0.0,0.0
m8 [family planning],8.17.1,Complications following male sterilization,2023-05-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-05-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-05-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-05-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-05-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-05-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-05-01,9.0,0.00012657159733355834
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-05-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-06-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-06-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-06-01,2.0,2.8127021629679632e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-06-01,11.0,0.00015469861896323797
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-06-01,1.0,1.4063510814839816e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-06-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-06-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-06-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-06-01,6.0,8.43810648890389e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-06-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-06-01,10.0,0.00014063510814839815
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-06-01,12.0,0.0001687621297780778
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-06-01,8.0,0.00011250808651871853
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-06-01,2.0,2.8127021629679632e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-06-01,32.0,0.0004500323460748741
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-06-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-06-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-06-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-06-01,0.0,0.0
m8 [family planning],8.17.1,Complications following male sterilization,2023-06-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-06-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-06-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-06-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-06-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-06-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-06-01,20.0,0.0002812702162967963
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-06-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-07-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-07-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-07-01,2.0,2.8127021629679632e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-07-01,4.0,5.6254043259359264e-05
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-07-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-07-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-07-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-07-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-07-01,6.0,8.43810648890389e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-07-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-07-01,12.0,0.0001687621297780778
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-07-01,10.0,0.00014063510814839815
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-07-01,12.0,0.0001687621297780778
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-07-01,8.0,0.00011250808651871853
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-07-01,30.0,0.0004219053244451945
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-07-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-07-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-07-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-07-01,252.0,0.0035440047253396337
m8 [family planning],8.17.1,Complications following male sterilization,2023-07-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-07-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-07-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-07-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-07-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-07-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-07-01,12.0,0.0001687621297780778
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-07-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-08-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-08-01,2.0,2.8127021629679632e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-08-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-08-01,12.0,0.0001687621297780778
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-08-01,3.0,4.219053244451945e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-08-01,12.0,0.0001687621297780778
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-08-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-08-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-08-01,10.0,0.00014063510814839815
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-08-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-08-01,8.0,0.00011250808651871853
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-08-01,6.0,8.43810648890389e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-08-01,2.0,2.8127021629679632e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-08-01,0.0,0.0
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-08-01,40.0,0.0005625404325935926
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-08-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-08-01,2.0,2.8127021629679632e-05
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-08-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-08-01,386.0,0.005428515174528169
m8 [family planning],8.17.1,Complications following male sterilization,2023-08-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-08-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-08-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-08-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-08-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-08-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-08-01,13.0,0.00018282564059291762
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-08-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-09-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-09-01,7.0,9.844457570387872e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-09-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-09-01,8.0,0.00011250808651871853
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-09-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-09-01,8.0,0.00011250808651871853
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-09-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-09-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-09-01,3.0,4.219053244451945e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-09-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-09-01,4.0,5.6254043259359264e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-09-01,7.0,9.844457570387872e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-09-01,8.0,0.00011250808651871853
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-09-01,3.0,4.219053244451945e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-09-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-09-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-09-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-09-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-09-01,309.0,0.0043456248417855035
m8 [family planning],8.17.1,Complications following male sterilization,2023-09-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-09-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-09-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-09-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-09-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-09-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-09-01,18.0,0.0002531431946671167
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-09-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-10-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-10-01,6.0,8.43810648890389e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-10-01,1.0,1.4063510814839816e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-10-01,4.0,5.6254043259359264e-05
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-10-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-10-01,12.0,0.0001687621297780778
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-10-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-10-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-10-01,8.0,0.00011250808651871853
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-10-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-10-01,12.0,0.0001687621297780778
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-10-01,8.0,0.00011250808651871853
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-10-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-10-01,10.0,0.00014063510814839815
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-10-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-10-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-10-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-10-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-10-01,72.0,0.0010125727786684667
m8 [family planning],8.17.1,Complications following male sterilization,2023-10-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-10-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-10-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-10-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-10-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-10-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-10-01,94.0,0.0013219700165949427
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-10-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-11-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-11-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-11-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-11-01,8.0,0.00011250808651871853
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-11-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-11-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-11-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-11-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-11-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-11-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-11-01,6.0,8.43810648890389e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-11-01,12.0,0.0001687621297780778
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-11-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-11-01,0.0,0.0
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-11-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-11-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-11-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-11-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-11-01,66.0,0.0009281917137794279
m8 [family planning],8.17.1,Complications following male sterilization,2023-11-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-11-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-11-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-11-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-11-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-11-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-11-01,15.0,0.00021095266222259724
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-11-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2023-12-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2023-12-01,7.0,9.844457570387872e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2023-12-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2023-12-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2023-12-01,1.0,1.4063510814839816e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2023-12-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2023-12-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2023-12-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2023-12-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2023-12-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2023-12-01,8.0,0.00011250808651871853
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2023-12-01,12.0,0.0001687621297780778
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2023-12-01,2.0,2.8127021629679632e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2023-12-01,4.0,5.6254043259359264e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2023-12-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2023-12-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2023-12-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2023-12-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2023-12-01,95.0,0.0013360335274097824
m8 [family planning],8.17.1,Complications following male sterilization,2023-12-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2023-12-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2023-12-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2023-12-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2023-12-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2023-12-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2023-12-01,8.0,0.00011250808651871853
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2023-12-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-01-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-01-01,8.0,0.00011250808651871853
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-01-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-01-01,12.0,0.0001687621297780778
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-01-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-01-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-01-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-01-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-01-01,6.0,8.43810648890389e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-01-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-01-01,4.0,5.6254043259359264e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-01-01,2.0,2.8127021629679632e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-01-01,1.0,1.4063510814839816e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-01-01,1.0,1.4063510814839816e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-01-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-01-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-01-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-01-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-01-01,0.0,0.0
m8 [family planning],8.17.1,Complications following male sterilization,2024-01-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-01-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-01-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-01-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-01-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-01-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-01-01,16.0,0.00022501617303743706
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-01-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-02-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-02-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-02-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-02-01,6.0,8.43810648890389e-05
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-02-01,1.0,1.4063510814839816e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-02-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-02-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-02-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-02-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-02-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-02-01,4.0,5.6254043259359264e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-02-01,2.0,2.8127021629679632e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-02-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-02-01,2.0,2.8127021629679632e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-02-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-02-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-02-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-02-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-02-01,66.0,0.0009281917137794279
m8 [family planning],8.17.1,Complications following male sterilization,2024-02-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-02-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-02-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-02-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-02-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-02-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-02-01,12.0,0.0001687621297780778
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-02-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-03-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-03-01,11.0,0.00015469861896323797
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-03-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-03-01,12.0,0.0001687621297780778
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-03-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-03-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-03-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-03-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-03-01,8.0,0.00011250808651871853
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-03-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-03-01,6.0,8.43810648890389e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-03-01,7.0,9.844457570387872e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-03-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-03-01,4.0,5.6254043259359264e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-03-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-03-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-03-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-03-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-03-01,78.0,0.0010969538435575057
m8 [family planning],8.17.1,Complications following male sterilization,2024-03-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-03-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-03-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-03-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-03-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-03-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-03-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-03-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-04-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-04-01,10.0,0.00014063510814839815
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-04-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-04-01,13.0,0.00018282564059291762
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-04-01,1.0,1.4063510814839816e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-04-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-04-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-04-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-04-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-04-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-04-01,6.0,8.43810648890389e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-04-01,2.0,2.8127021629679632e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-04-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-04-01,4.0,5.6254043259359264e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-04-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-04-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-04-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-04-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-04-01,108.0,0.0015188591680027
m8 [family planning],8.17.1,Complications following male sterilization,2024-04-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-04-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-04-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-04-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-04-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-04-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-04-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-04-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-05-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-05-01,13.0,0.00018282564059291762
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-05-01,5.0,7.031755407419908e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-05-01,14.0,0.00019688915140775743
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-05-01,1.0,1.4063510814839816e-05
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-05-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-05-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-05-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-05-01,6.0,8.43810648890389e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-05-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-05-01,8.0,0.00011250808651871853
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-05-01,4.0,5.6254043259359264e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-05-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-05-01,5.0,7.031755407419908e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-05-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-05-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-05-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-05-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-05-01,100.0,0.0014063510814839816
m8 [family planning],8.17.1,Complications following male sterilization,2024-05-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-05-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-05-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-05-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-05-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-05-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-05-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-05-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-06-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-06-01,6.0,8.43810648890389e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-06-01,1.0,1.4063510814839816e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-06-01,9.0,0.00012657159733355834
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-06-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-06-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-06-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-06-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-06-01,6.0,8.43810648890389e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-06-01,8.0,0.00011250808651871853
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-06-01,4.0,5.6254043259359264e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-06-01,4.0,5.6254043259359264e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-06-01,5.0,7.031755407419908e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-06-01,0.0,0.0
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-06-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-06-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-06-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-06-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-06-01,67.0,0.0009422552245942677
m8 [family planning],8.17.1,Complications following male sterilization,2024-06-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-06-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-06-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-06-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-06-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-06-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-06-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-06-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-07-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-07-01,3.0,4.219053244451945e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-07-01,1.0,1.4063510814839816e-05
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-07-01,8.0,0.00011250808651871853
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-07-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-07-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-07-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-07-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-07-01,4.0,5.6254043259359264e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-07-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-07-01,8.0,0.00011250808651871853
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-07-01,4.0,5.6254043259359264e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-07-01,4.0,5.6254043259359264e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-07-01,5.0,7.031755407419908e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-07-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-07-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-07-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-07-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-07-01,90.0,0.0012657159733355835
m8 [family planning],8.17.1,Complications following male sterilization,2024-07-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-07-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-07-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-07-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-07-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-07-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-07-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-07-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-08-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-08-01,4.0,5.6254043259359264e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-08-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-08-01,7.0,9.844457570387872e-05
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-08-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-08-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-08-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-08-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-08-01,2.0,2.8127021629679632e-05
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-08-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-08-01,2.0,2.8127021629679632e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-08-01,1.0,1.4063510814839816e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-08-01,3.0,4.219053244451945e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-08-01,0.0,0.0
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-08-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-08-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-08-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-08-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-08-01,66.0,0.0009281917137794279
m8 [family planning],8.17.1,Complications following male sterilization,2024-08-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-08-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-08-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-08-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-08-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-08-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-08-01,12.0,0.0001687621297780778
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-08-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-09-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-09-01,7.0,9.844457570387872e-05
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-09-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-09-01,8.0,0.00011250808651871853
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-09-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-09-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-09-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-09-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-09-01,0.0,0.0
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-09-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-09-01,0.0,0.0
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-09-01,0.0,0.0
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-09-01,0.0,0.0
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-09-01,0.0,0.0
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-09-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-09-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-09-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-09-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-09-01,0.0,0.0
m8 [family planning],8.17.1,Complications following male sterilization,2024-09-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-09-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-09-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-09-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-09-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-09-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-09-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-09-01,0.0,0.0
m8 [family planning],8.1.1,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted,2024-10-01,0.0,0.0
m8 [family planning],8.2.1,Number of Laparoscopic sterilizations (excluding post-abortion) conducted,2024-10-01,10.0,0.00014063510814839815
m8 [family planning],8.2.2,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted,2024-10-01,0.0,0.0
m8 [family planning],8.2.3,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted,2024-10-01,13.0,0.00018282564059291762
m8 [family planning],8.2.4,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted,2024-10-01,0.0,0.0
m8 [family planning],8.3,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD),2024-10-01,0.0,0.0
m8 [family planning],8.4,Number of Postpartum (within 48 hours of delivery) IUCD insertions,2024-10-01,0.0,0.0
m8 [family planning],8.5,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions,2024-10-01,0.0,0.0
m8 [family planning],8.6,Number of IUCD Removals ,2024-10-01,0.0,0.0
m8 [family planning],8.7,Number of complications following IUCD Insertion,2024-10-01,0.0,0.0
m8 [family planning],8.8,Injectable Contraceptive MPA- First Dose,2024-10-01,2.0,2.8127021629679632e-05
m8 [family planning],8.9,Injectable Contraceptive MPA- Second Dose,2024-10-01,4.0,5.6254043259359264e-05
m8 [family planning],8.1,Injectable Contraceptive MPA- Third Dose,2024-10-01,6.0,8.43810648890389e-05
m8 [family planning],8.11,Injectable Contraceptive MPA- Fourth and above Dose,2024-10-01,2.0,2.8127021629679632e-05
m8 [family planning],8.12,Number of Combined Oral Pill cycles distributed to the beneficiary,2024-10-01,0.0,0.0
m8 [family planning],8.13,Number of Condom pieces distributed to the beneficiary,2024-10-01,0.0,0.0
m8 [family planning],8.14,Number of Centchroman (weekly) pill strips distributed to the beneficiary,2024-10-01,0.0,0.0
m8 [family planning],8.15,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary,2024-10-01,0.0,0.0
m8 [family planning],8.16,Number of Pregnancy Test Kits (PTK) utilized,2024-10-01,65.0,0.000914128202964588
m8 [family planning],8.17.1,Complications following male sterilization,2024-10-01,0.0,0.0
m8 [family planning],8.17.2,Complications following female sterilization ,2024-10-01,0.0,0.0
m8 [family planning],8.17.3,Failures following male sterilization,2024-10-01,0.0,0.0
m8 [family planning],8.17.4,Failures following female sterilization,2024-10-01,0.0,0.0
m8 [family planning],8.17.5,Deaths following male sterilization,2024-10-01,0.0,0.0
m8 [family planning],8.17.6,Deaths following female sterilization,2024-10-01,0.0,0.0
m8 [family planning],8.18.1,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier),2024-10-01,0.0,0.0
m8 [family planning],8.18.2,Number of cases of Male Sterilization followed up (after 3 months),2024-10-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-04-01,99.0,0.0013922875706691418
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-04-01,99.0,0.0013922875706691418
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-04-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-04-01,99.0,0.0013922875706691418
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-04-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-04-01,99.0,0.0013922875706691418
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-04-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-04-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-04-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-04-01,0.0,0.0
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-04-01,12.0,0.0001687621297780778
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-04-01,14.0,0.00019688915140775743
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-04-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-04-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-04-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-04-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-04-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-04-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-04-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-04-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-04-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-04-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-04-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-04-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-04-01,26.0,0.00036565128118583524
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-04-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-04-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-05-01,109.0,0.0015329226788175399
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-05-01,109.0,0.0015329226788175399
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-05-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-05-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-05-01,109.0,0.0015329226788175399
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-05-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-05-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-05-01,109.0,0.0015329226788175399
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-05-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-05-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-05-01,28.0,0.00039377830281551486
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-05-01,28.0,0.00039377830281551486
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-05-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-05-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-05-01,0.0,0.0
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-05-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-05-01,8.0,0.00011250808651871853
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-05-01,8.0,0.00011250808651871853
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-05-01,9.0,0.00012657159733355834
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-05-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-05-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-05-01,19.0,0.0002672067054819565
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-05-01,19.0,0.0002672067054819565
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-05-01,19.0,0.0002672067054819565
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-05-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-05-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-05-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-05-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-05-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-05-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-05-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-05-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-05-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-05-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-05-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-05-01,16.0,0.00022501617303743706
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-05-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-05-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-06-01,112.0,0.0015751132112620594
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-06-01,112.0,0.0015751132112620594
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-06-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-06-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-06-01,112.0,0.0015751132112620594
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-06-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-06-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-06-01,112.0,0.0015751132112620594
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-06-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-06-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-06-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-06-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-06-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-06-01,36.0,0.0005062863893342334
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-06-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-06-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-06-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-06-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-06-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-06-01,16.0,0.00022501617303743706
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-06-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-06-01,30.0,0.0004219053244451945
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-06-01,30.0,0.0004219053244451945
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-06-01,30.0,0.0004219053244451945
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-06-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-06-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-06-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-06-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-06-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-06-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-06-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-06-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-06-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-06-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-06-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-06-01,35.0,0.0004922228785193936
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-06-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-06-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-07-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-07-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-07-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-07-01,46.0,0.0006469214974826315
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-07-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-07-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-07-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-07-01,46.0,0.0006469214974826315
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-07-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-07-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-07-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-07-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-07-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-07-01,46.0,0.0006469214974826315
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-07-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-07-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-07-01,30.0,0.0004219053244451945
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-07-01,29.0,0.00040784181363035465
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-07-01,29.0,0.00040784181363035465
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-07-01,29.0,0.00040784181363035465
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-07-01,29.0,0.00040784181363035465
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-07-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-07-01,10.0,0.00014063510814839815
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-07-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-07-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-07-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-07-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-07-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-07-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-07-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-07-01,16.0,0.00022501617303743706
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-07-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-07-01,10.0,0.00014063510814839815
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-07-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-07-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-07-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-07-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-07-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-07-01,19.0,0.0002672067054819565
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-07-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-07-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-08-01,125.0,0.001757938851854977
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-08-01,125.0,0.001757938851854977
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-08-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-08-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-08-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-08-01,125.0,0.001757938851854977
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-08-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-08-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-08-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-08-01,125.0,0.001757938851854977
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-08-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-08-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-08-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-08-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-08-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-08-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-08-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-08-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-08-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-08-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-08-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-08-01,9.0,0.00012657159733355834
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-08-01,10.0,0.00014063510814839815
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-08-01,1.0,1.4063510814839816e-05
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-08-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-08-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-08-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-08-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-08-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-08-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-08-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-08-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-08-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-08-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-08-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-08-01,1.0,1.4063510814839816e-05
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-08-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-08-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-08-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-08-01,19.0,0.0002672067054819565
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-08-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-08-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-09-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-09-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-09-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-09-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-09-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-09-01,106.0,0.0014907321463730205
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-09-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-09-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-09-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-09-01,7.0,9.844457570387872e-05
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-09-01,11.0,0.00015469861896323797
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-09-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-09-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-09-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-09-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-09-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-09-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-09-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-09-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-09-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-09-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-09-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-09-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-09-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-09-01,17.0,0.00023907968385227687
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-09-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-09-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-10-01,136.0,0.001912637470818215
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-10-01,136.0,0.001912637470818215
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-10-01,41.0,0.0005766039434084325
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-10-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-10-01,136.0,0.001912637470818215
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-10-01,41.0,0.0005766039434084325
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-10-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-10-01,136.0,0.001912637470818215
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-10-01,41.0,0.0005766039434084325
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-10-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-10-01,41.0,0.0005766039434084325
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-10-01,36.0,0.0005062863893342334
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-10-01,41.0,0.0005766039434084325
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-10-01,36.0,0.0005062863893342334
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-10-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-10-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-10-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-10-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-10-01,12.0,0.0001687621297780778
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-10-01,10.0,0.00014063510814839815
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-10-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-10-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-10-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-10-01,28.0,0.00039377830281551486
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-10-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-10-01,1.0,1.4063510814839816e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-10-01,1.0,1.4063510814839816e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-10-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-10-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-10-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-10-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-10-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-10-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-10-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-10-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-10-01,10.0,0.00014063510814839815
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-10-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-10-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-11-01,116.0,0.0016313672545214186
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-11-01,116.0,0.0016313672545214186
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-11-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-11-01,33.0,0.00046409585688971395
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-11-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-11-01,116.0,0.0016313672545214186
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-11-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-11-01,33.0,0.00046409585688971395
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-11-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-11-01,116.0,0.0016313672545214186
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-11-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-11-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-11-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-11-01,33.0,0.00046409585688971395
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-11-01,35.0,0.0004922228785193936
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-11-01,30.0,0.0004219053244451945
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-11-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-11-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-11-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-11-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-11-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-11-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-11-01,14.0,0.00019688915140775743
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-11-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-11-01,29.0,0.00040784181363035465
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-11-01,29.0,0.00040784181363035465
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-11-01,29.0,0.00040784181363035465
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-11-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-11-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-11-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-11-01,1.0,1.4063510814839816e-05
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-11-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-11-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-11-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-11-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-11-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-11-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-11-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-11-01,20.0,0.0002812702162967963
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-11-01,9.0,0.00012657159733355834
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-11-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2023-12-01,134.0,0.0018845104491885354
m9 [child immunisation],9.1.2,Child immunisation - BCG,2023-12-01,134.0,0.0018845104491885354
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2023-12-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2023-12-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2023-12-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2023-12-01,134.0,0.0018845104491885354
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2023-12-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2023-12-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2023-12-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2023-12-01,134.0,0.0018845104491885354
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2023-12-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2023-12-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2023-12-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2023-12-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2023-12-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2023-12-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2023-12-01,29.0,0.00040784181363035465
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2023-12-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2023-12-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2023-12-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2023-12-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2023-12-01,13.0,0.00018282564059291762
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2023-12-01,7.0,9.844457570387872e-05
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2023-12-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2023-12-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2023-12-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2023-12-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2023-12-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2023-12-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2023-12-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2023-12-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2023-12-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2023-12-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2023-12-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2023-12-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2023-12-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2023-12-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2023-12-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2023-12-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2023-12-01,8.0,0.00011250808651871853
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2023-12-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2023-12-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2023-12-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2023-12-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2023-12-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2023-12-01,20.0,0.0002812702162967963
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2023-12-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2023-12-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-01-01,113.0,0.0015891767220768992
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-01-01,113.0,0.0015891767220768992
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-01-01,45.0,0.0006328579866677918
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-01-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-01-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-01-01,113.0,0.0015891767220768992
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-01-01,45.0,0.0006328579866677918
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-01-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-01-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-01-01,113.0,0.0015891767220768992
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-01-01,45.0,0.0006328579866677918
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-01-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-01-01,45.0,0.0006328579866677918
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-01-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-01-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-01-01,45.0,0.0006328579866677918
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-01-01,27.0,0.000379714792000675
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-01-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-01-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-01-01,0.0,0.0
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-01-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-01-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-01-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-01-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-01-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-01-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-01-01,12.0,0.0001687621297780778
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-01-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-01-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-01-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-01-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-01-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-01-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-01-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-01-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-01-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-01-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-01-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-01-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-01-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-01-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-02-01,126.0,0.0017720023626698169
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-02-01,126.0,0.0017720023626698169
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-02-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-02-01,126.0,0.0017720023626698169
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-02-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-02-01,126.0,0.0017720023626698169
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-02-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-02-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-02-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-02-01,24.0,0.0003375242595561556
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-02-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-02-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-02-01,0.0,0.0
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-02-01,35.0,0.0004922228785193936
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-02-01,10.0,0.00014063510814839815
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-02-01,25.0,0.0003515877703709954
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-02-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-02-01,0.0,0.0
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-02-01,0.0,0.0
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-02-01,0.0,0.0
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-02-01,0.0,0.0
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-02-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-02-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-02-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-02-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-02-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-02-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-02-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-02-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-02-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-02-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-02-01,22.0,0.00030939723792647593
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-02-01,9.0,0.00012657159733355834
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-02-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-03-01,138.0,0.0019407644924478945
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-03-01,138.0,0.0019407644924478945
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-03-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-03-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-03-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-03-01,138.0,0.0019407644924478945
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-03-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-03-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-03-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-03-01,138.0,0.0019407644924478945
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-03-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-03-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-03-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-03-01,25.0,0.0003515877703709954
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-03-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-03-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-03-01,22.0,0.00030939723792647593
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-03-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-03-01,13.0,0.00018282564059291762
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-03-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-03-01,16.0,0.00022501617303743706
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-03-01,20.0,0.0002812702162967963
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-03-01,11.0,0.00015469861896323797
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-03-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-03-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-03-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-03-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-03-01,3.0,4.219053244451945e-05
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-03-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-03-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-03-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-03-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-03-01,19.0,0.0002672067054819565
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-03-01,19.0,0.0002672067054819565
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-03-01,15.0,0.00021095266222259724
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-03-01,7.0,9.844457570387872e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-03-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-03-01,10.0,0.00014063510814839815
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-03-01,26.0,0.00036565128118583524
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-03-01,11.0,0.00015469861896323797
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-03-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-03-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-03-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-03-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-03-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-03-01,16.0,0.00022501617303743706
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-03-01,19.0,0.0002672067054819565
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-03-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-04-01,165.0,0.0023204792844485696
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-04-01,165.0,0.0023204792844485696
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-04-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-04-01,165.0,0.0023204792844485696
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-04-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-04-01,165.0,0.0023204792844485696
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-04-01,23.0,0.00032346074874131577
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-04-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-04-01,11.0,0.00015469861896323797
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-04-01,8.0,0.00011250808651871853
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-04-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-04-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-04-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-04-01,18.0,0.0002531431946671167
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-04-01,18.0,0.0002531431946671167
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-04-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-04-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-04-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-04-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-04-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-04-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-04-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-04-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-04-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-04-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-04-01,19.0,0.0002672067054819565
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-04-01,12.0,0.0001687621297780778
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-04-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-05-01,181.0,0.0025454954574860066
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-05-01,181.0,0.0025454954574860066
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-05-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-05-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-05-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-05-01,181.0,0.0025454954574860066
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-05-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-05-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-05-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-05-01,181.0,0.0025454954574860066
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-05-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-05-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-05-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-05-01,22.0,0.00030939723792647593
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-05-01,21.0,0.00029533372711163615
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-05-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-05-01,21.0,0.00029533372711163615
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-05-01,11.0,0.00015469861896323797
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-05-01,14.0,0.00019688915140775743
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-05-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-05-01,24.0,0.0003375242595561556
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-05-01,24.0,0.0003375242595561556
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-05-01,24.0,0.0003375242595561556
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-05-01,24.0,0.0003375242595561556
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-05-01,4.0,5.6254043259359264e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-05-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-05-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-05-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-05-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-05-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-05-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-05-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-05-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-05-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-05-01,25.0,0.0003515877703709954
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-05-01,24.0,0.0003375242595561556
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-05-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-06-01,140.0,0.0019688915140775743
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-06-01,140.0,0.0019688915140775743
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-06-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-06-01,18.0,0.0002531431946671167
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-06-01,140.0,0.0019688915140775743
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-06-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-06-01,18.0,0.0002531431946671167
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-06-01,140.0,0.0019688915140775743
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-06-01,18.0,0.0002531431946671167
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-06-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-06-01,18.0,0.0002531431946671167
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-06-01,44.0,0.0006187944758529519
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-06-01,18.0,0.0002531431946671167
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-06-01,28.0,0.00039377830281551486
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-06-01,28.0,0.00039377830281551486
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-06-01,28.0,0.00039377830281551486
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-06-01,28.0,0.00039377830281551486
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-06-01,0.0,0.0
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-06-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-06-01,14.0,0.00019688915140775743
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-06-01,14.0,0.00019688915140775743
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-06-01,14.0,0.00019688915140775743
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-06-01,14.0,0.00019688915140775743
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-06-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-06-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-06-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-06-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-06-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-06-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-06-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-06-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-06-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-06-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-06-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-06-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-06-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-07-01,122.0,0.0017157483194104575
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-07-01,122.0,0.0017157483194104575
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-07-01,34.0,0.00047815936770455374
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-07-01,122.0,0.0017157483194104575
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-07-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-07-01,34.0,0.00047815936770455374
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-07-01,122.0,0.0017157483194104575
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-07-01,34.0,0.00047815936770455374
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-07-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-07-01,34.0,0.00047815936770455374
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-07-01,37.0,0.0005203499001490731
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-07-01,34.0,0.00047815936770455374
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-07-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-07-01,17.0,0.00023907968385227687
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-07-01,15.0,0.00021095266222259724
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-07-01,19.0,0.0002672067054819565
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-07-01,15.0,0.00021095266222259724
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-07-01,14.0,0.00019688915140775743
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-07-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-07-01,17.0,0.00023907968385227687
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-07-01,17.0,0.00023907968385227687
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-07-01,17.0,0.00023907968385227687
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-07-01,17.0,0.00023907968385227687
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-07-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-07-01,5.0,7.031755407419908e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-07-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-07-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-07-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-07-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-07-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-07-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-07-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-07-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-07-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-07-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-07-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-08-01,172.0,0.0024189238601524483
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-08-01,172.0,0.0024189238601524483
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-08-01,38.0,0.000534413410963913
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-08-01,172.0,0.0024189238601524483
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-08-01,38.0,0.000534413410963913
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-08-01,172.0,0.0024189238601524483
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-08-01,38.0,0.000534413410963913
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-08-01,38.0,0.000534413410963913
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-08-01,29.0,0.00040784181363035465
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-08-01,38.0,0.000534413410963913
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-08-01,17.0,0.00023907968385227687
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-08-01,17.0,0.00023907968385227687
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-08-01,17.0,0.00023907968385227687
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-08-01,17.0,0.00023907968385227687
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-08-01,0.0,0.0
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-08-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-08-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-08-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-08-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-08-01,13.0,0.00018282564059291762
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-08-01,0.0,0.0
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-08-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-08-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-08-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-08-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-08-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-08-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-08-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-08-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-08-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-08-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-08-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-08-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-09-01,158.0,0.002222034708744691
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-09-01,158.0,0.002222034708744691
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-09-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-09-01,31.0,0.00043596883526003427
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-09-01,158.0,0.002222034708744691
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-09-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-09-01,31.0,0.00043596883526003427
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-09-01,158.0,0.002222034708744691
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-09-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-09-01,31.0,0.00043596883526003427
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-09-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-09-01,24.0,0.0003375242595561556
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-09-01,31.0,0.00043596883526003427
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-09-01,40.0,0.0005625404325935926
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-09-01,31.0,0.00043596883526003427
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-09-01,27.0,0.000379714792000675
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-09-01,62.0,0.0008719376705200685
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-09-01,60.0,0.000843810648890389
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-09-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-09-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-09-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-09-01,13.0,0.00018282564059291762
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-09-01,13.0,0.00018282564059291762
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-09-01,6.0,8.43810648890389e-05
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-09-01,0.0,0.0
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-09-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-09-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-09-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-09-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-09-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-09-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-09-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-09-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-09-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-09-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-09-01,0.0,0.0
m9 [child immunisation],9.1.1,Child immunisation - Vitamin K (Birth Dose),2024-10-01,189.0,0.0026580035440047253
m9 [child immunisation],9.1.2,Child immunisation - BCG,2024-10-01,184.0,0.002587685989930526
m9 [child immunisation],9.1.3,Child immunisation - Pentavalent 1,2024-10-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.4,Child immunisation - Pentavalent 2,2024-10-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.5,Child immunisation - Pentavalent 3,2024-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.6,Child immunisation - OPV 0 (Birth Dose),2024-10-01,184.0,0.002587685989930526
m9 [child immunisation],9.1.7,Child immunisation - OPV1,2024-10-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.8,Child immunisation - OPV2,2024-10-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.9,Child immunisation - OPV3,2024-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.10,Child immunisation - Hepatitis-B0 (Birth Dose),2024-10-01,184.0,0.002587685989930526
m9 [child immunisation],9.1.11,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1),2024-10-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.12,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,2024-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.13,Child immunisation - Rotavirus 1,2024-10-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.14,Child immunisation - Rotavirus 2,2024-10-01,27.0,0.000379714792000675
m9 [child immunisation],9.1.15,Child immunisation - Rotavirus 3,2024-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.1.16,Child immunisation - PCV1,2024-10-01,43.0,0.0006047309650381121
m9 [child immunisation],9.1.17,Child immunisation - PCV2,2024-10-01,26.0,0.00036565128118583524
m9 [child immunisation],9.2.1,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3),2024-10-01,21.0,0.00029533372711163615
m9 [child immunisation],9.2.2,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose,2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.2.3,Child immunisation (9-11months) - JE 1st dose,2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.2.4,Child immunisation - PCV Booster,2024-10-01,21.0,0.00029533372711163615
m9 [child immunisation],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male,2024-10-01,13.0,0.00018282564059291762
m9 [child immunisation],9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female,2024-10-01,8.0,0.00011250808651871853
m9 [child immunisation],9.3.1,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.2,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.3,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.4,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.5,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.6,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.7,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.3.8,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,2024-10-01,0.0,0.0
m9 [child immunisation],9.4.1,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months),2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.2,Child immunisation - DPT 1st Booster ,2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.3,Child immunisation - OPV Booster,2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.4.4,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months),2024-10-01,15.0,0.00021095266222259724
m9 [child immunisation],9.5.1,Child Immunization- Typhoid,2024-10-01,10.0,0.00014063510814839815
m9 [child immunisation],9.5.2,Children more than 5 years received DPT5 (2nd Booster),2024-10-01,2.0,2.8127021629679632e-05
m9 [child immunisation],9.5.3,Children more than 10 years received Td10 (Tetanus Diptheria10),2024-10-01,0.0,0.0
m9 [child immunisation],9.5.4,Children more than 16 years received Td16 (Tetanus Diptheria16),2024-10-01,0.0,0.0
m9 [child immunisation],9.6.1,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc)",2024-10-01,0.0,0.0
m9 [child immunisation],9.6.2,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.)",2024-10-01,0.0,0.0
m9 [child immunisation],9.6.3,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.)",2024-10-01,0.0,0.0
m9 [child immunisation],9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths",2024-10-01,0.0,0.0
m9 [child immunisation],9.7.1,Immunisation sessions planned ,2024-10-01,0.0,0.0
m9 [child immunisation],9.7.2,Immunisation sessions held ,2024-10-01,0.0,0.0
m9 [child immunisation],9.8.1,Child immunisation - Vitamin A Dose - 1,2024-10-01,0.0,0.0
m9 [child immunisation],9.8.2,Child immunisation - Vitamin A Dose - 5,2024-10-01,0.0,0.0
m9 [child immunisation],9.8.3,Child immunisation - Vitamin A Dose - 9,2024-10-01,0.0,0.0
